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In this thesis, I describe a hypothetical journey of a tourist in New Zealand who has arrived on an 
airplane and is thirsty to explore the country’s spectacular rural and remote environments. My 
tourist sometimes will have to find her own drinking water. Surface waters in rural areas may be 
contaminated by waste from livestock, septic tanks, and wastewater pipes. These contaminants 
can include antibiotics and antibiotic resistant bacteria. When these surface waters are used for 
drinking and food preparation, they may expose users to antibiotic resistant pathogens, reducing 
treatment options and delivering poorer treatment outcomes. I was interested in whether these 
surface waters that are used for drinking water in various rural South Island locations harboured 
multidrug resistant (MDR) bacteria, and whether associations between resistance and location 
could be observed.  
 
The microbiological quality of water on long haul international and domestic flights was 
compared using E. coli as an indicator organism. Next, the number and diversity of MDR E. coli 
was measured and compared in rural areas across three water sources; treated water (Treated), 
untreated stream water (Stream), other untreated surface waters such as rivers and tributaries 
(Other). Comparisons were made between the Marlborough, Banks Peninsula and Wider 
Canterbury areas. Through a case study in Okains Bay I observed whether there were seasonal 
effects on MDR E. coli in the main drinking water sourced from the Opara Stream. 
 
E. coli was below the detection limit in the airplane water analysis, however, water from long 
haul international flights had significantly poorer microbiological quality than domestic 
airplanes. Across the three regions, 15% of tested isolates were MDR. Among the MDR isolates, 
1% were isolated from Treated, 46% were isolated from Other, and 53% were isolated from 
Stream. No antibiotic enrichment was needed to identify MDR E. coli from water samples. The 
E. coli population density was not predictive of resistant E. coli occurrence in the environment. 
In the Okains Bay case study, MDR E. coli were detected at similar frequencies between the sites 
along the Opara Stream across the four seasons. The residential home had significantly higher 
MDR frequencies than all the Opara Stream sites. 
 
36% of isolates that were resistant to ampicillin or ciprofloxacin were phenotypically confirmed 
to be ESBL or AmpC producers. 64% of tested isolates were able to share at least one resistance 
through horizontal gene transfer. Genetic analysis of 20 isolates indicated that a combination of 
point mutations, efflux systems and AmpC −lactamases are the putative contributors to 
resistance phenotypes observed in the sequenced isolates. 
 
Previous studies have determined that E. coli concentrations in rural surface waters are often 
above what is considered safe for drinking. Nevertheless, few studies have investigated the 
presence of MDR bacteria. The results from my analysis suggest that MDR E. coli and ESBL- 
and AmpC-producing E. coli are present in surface waters in Marlborough, Banks Peninsula, and 
the Wider Canterbury area. These MDR E. coli are able to share resistance genes with 
susceptible bacteria. An important finding with relevance to community safety is that the 
exposure to, and risk of, catching an infection from a MDR E. coli cannot be estimated using 
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Chapter 1: Antibiotics and resistance  
1.1 Antibiotics and resistance 
Antibiotic resistant bacteria are now commonly found in New Zealand’s surface waters 
(Schousboe et al., 2015; Van Hamelsveld et al., 2019; Winkworth-Lawrence & Lange, 2016), 
and the contribution of the environmental exposures to antibiotic resistant bacteria for human 
health is gaining attention (Karkman et al., 2019). Both here and internationally people are 
concerned (Ministry of Health & Ministry for Primary Industries, 2017a; World Health 
Organisation, 2014). This research was designed in response to those concerns. Primarily, it is an 
investigation into the occurrence and diversity of antimicrobial resistance (AMR) across the 
Marlborough, Banks Peninsula and Wider Canterbury areas at locations whose main drinking 
water was sourced from a nearby fresh surface water. 
 
Increasing amounts of antibiotics/antimicrobial agents are being introduced into the 
environment. They are used, for example, in dairy farming where they are being linked with 
multidrug resistant (MDR) bacteria (Collis et al., 2019), through human therapeutics where the 
misuse and overuse of antibiotics have been associated with MDR pathogens (Davies & Davies, 
2010), and even through veterinary medicine (Teuber, 2001). People may be exposed to resistant 
bacteria through different forms of contact with water. We drink it and play in it; we touch our 
companion animals after they swim in it; we harvest food from it. This thesis describes my 
findings. Firstly, I measured water quality by enumerating the bacterium Escherichia coli. 
Secondly, I determined the frequency of MDR E. coli. Thirdly, I determined the potential for E. 
coli to spread resistant determinants through horizontal gene transfer. Finally, I used whole 
genome sequencing of selected isolates to infer the underlying genetic basis of resistance.   
 
Antibiotic resistance is a global crisis. In the United States, around 3 million people a year are 
infected with a high-priority antibiotic resistant pathogen. Resistant isolates requiring a public 
health investigation are detected every 4 hours (U.S. Centers for Disease Control and Prevention, 
2019). On the global scale, over 700,000 deaths annually are attributed to antibiotic resistant 
infections (O'Neill, 2016). The World Health Organisation (WHO) estimates that this number 
will be over 10 million by 2050 (Tagliabue & Rappuoli, 2018).  
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Resistance to the watershed antibiotic penicillin was detected in bacteria that previously had 
been susceptible within two years of its discovery (Walsh, 2003). Since then, the successive 
deployment of new antibiotics has been followed by the emergence of resistant strains (Manohar 
et al., 2020), with clinically significant resistance to novel antibiotics observed within a few 
months to a few years (Neu, 1992). Antibiotic resistance is common in nature, but prior to the 
human adoption of antibiotics in medicine and agriculture, resistant bacteria species that cause 
disease in people and companion animals was rare or absent. The use of antibiotics has rapidly 
sped up this evolution, contributing to the antibiotic ‘resistome’ in the environment (McEwen & 
Collignon, 2018). The antibiotic ‘resistome’ describes the collection of bacterial antibiotic 
resistance genes and all other resistance genes (Wright, 2007). Bacteria can encounter antibiotics 
during their use as chemotherapy, usually for bacterial infections. Antibiotic treatment and 
dosage in humans are determined by pharmacokinetic and pharmacodynamic models (Kurenbach 
et al., 2015), and these models are based on information measured in vitro (Steinkraus et al., 
2007). Bacteria also encounter antibiotic residues in the environment. The contamination of 
antibiotic residues into environments such as surface waters can create a selective environment 
which can lead to overexpression of bacterial defensive systems such as efflux pumps and can 
select for bacteria that have mutations which allow them to survive (Lupo et al., 2012). 
 
Bacterial resistance can be intrinsic, adaptive or acquired (Arzanlou et al., 2017). Intrinsic 
resistance mechanisms can occur through inherent structures or functions that allow the 
bacterium to tolerate antibiotics, for example, the selective permeability of the membrane or 
efflux pumps (Mazzariol et al., 2000). In this way, Gram-negative bacteria are intrinsically more 
resistant to antibiotics than Gram-positive bacteria due to the differences in the membrane 
structures (Zgurskaya et al., 2015). Transient bacterial resistance can occur through exposures to 
sub-lethal concentrations of antibiotics, and as the concentrations increase, high-level resistance 
can be observed. This type of adaptive resistance is governed by epigenetic inheritance and 
inducible gene expression (Motta et al., 2015). Acquired resistance describes two kinds of 
origins: horizontal gene transfer and mutation. The movement of mobile genetic elements such 
as plasmids and integrons from resistant bacteria via horizontal gene transfer has been identified 
as one of the significant contributors to the dissemination of antibiotic resistant bacteria in the 
environment (Dantas & Sommer, 2012), with plasmid-mediated conjugation being amongst the 
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most important routes (Davies, 1994). For instance, the efflux gene tetL associated with 
tetracycline resistance is found on conjugative plasmids (Chopra & Roberts, 2001). Another 
manner of acquiring resistance is through mutations in the bacterial genome which reduces the 
antibiotic’s affinity for the target enzyme, for example, resistance to the antibiotic rifampicin can 
occur from a mutation in the rpoB subunit of RNA polymerase (Jin & Gross, 1988).   
 
In the past few decades, the emergence of MDR, extensively drug-resistant (XDR) and pandrug-
resistant (PDR) bacteria have caused increased concern as they pose a significant threat to human 
therapeutics and limit the current antibiotic treatments that we use to combat infections 
(Magiorakos et al., 2012). MDR is described as resistance to at least one antibiotic in three or 
more antibiotic categories, XDR is described as resistance to all but two or fewer antibiotic 
categories, and PDR is described as resistance to all antibiotics in all antibiotic categories 
(Magiorakos et al., 2012). On a global scale, extended-spectrum β-lactamase (ESBL)-producing 
bacteria, methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant 
enterococci (VRE) have become of particular concern from a healthcare perspective as they are 
able to confer resistance to wide array of antibiotics and can lead to poor treatment outcomes 
(Hassoun et al., 2017; Murray, 1997; Paterson & Bonomo, 2005).  
 
1.2 Use and surveillance of antibiotics in society 
Antibiotic resistant bacteria have been a global issue that has existed in humans, animals, food 
and the environment for decades (Davies & Davies, 2010). Understanding the patterns and 
frequency of antibiotic use and antibiotic resistant organisms in society and in the environment 
allows monitoring agencies and governments to fulfil their roles in antimicrobial stewardship. 
The aim of antimicrobial stewardship is to protect people from untreatable infections but also to 
preserve the effectiveness of antibiotics in the future (Best Practice Advocacy Centre New 
Zealand and National Institute for Health and Care Excellence, 2017).  
 
The use of antibiotics is common in agriculture and in human and veterinary medicine. Concerns 
surrounding antibiotic resistance encompasses all three areas, with the misuse or overuse of 
antibiotics in each sector spreading resistant bacteria and resistant determinants within and 
between each sector (McEwen & Collignon, 2018). Links between human, animal (veterinary) 
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and food-producing animal diseases have been identified since the 19th century, which 
encouraged the ‘One Health’ approach, where the similarities between human and animal 
antibiotic uses were identified, and it was realized that collaboration across policy makers, 
clinicians and researchers were needed to prevent and control zoonotic diseases (Cassidy, 2017).  
 
The exact quantity of antibiotics used in food production is difficult to measure. However, in 
2017, it was estimated that on a global scale 93,309 tonnes of antibiotics was used in food-
producing livestock, and it was predicted that by 2030, this number would rise to 104,079 tonnes 
(Tiseo et al., 2020). Food-producing livestock and humans often use the same classes of 
antibiotics for therapy, which means that there is a high risk of the emerging resistant bacteria to 
cause infections in both humans and animals (World Health Organisation, 2014). In New 
Zealand, the sale of antibiotics in agriculture and veterinary medicine is monitored. Antibiotic 
use in food-producing animals is regulated under the Agricultural Compounds and Veterinary 
Medicines Act 1997, which permits the use of agricultural compounds (i.e., antibiotics) only if 
their benefit outweighs the risk from residues for humans and the environment (Ministry for 
Primary Industries, 2020). Antibiotics prescribed by veterinarians are used throughout New 
Zealand for therapeutic and non-therapeutic uses (Schallenberg & Armstrong, 2004). McDougall 
et al. (2017) found that New Zealand farmers had little knowledge around the occurrence of 
antibiotic resistant bacteria, let alone MDR bacteria. Most farmers in the study relied on their 
veterinarians’ advice regarding dosage and treatment, with dosage over the in vitro minimum 
inhibitory concentration (MIC) only considered in 21% of the cases. The most common 
antibiotic used in dairy and meat production are penicillins (Bryan & Hea, 2017). Nevertheless, 
resistances to other classes of antibiotics such as aminoglycosides (gentamicin, neomycin and 
streptomycin), quinolones (ciprofloxacin) and tetracyclines have been documented (Nulsen et al., 
2008).  
 
Currently in New Zealand, there are guidelines in place for antibiotic use in medicine, however, 
they are specific to each healthcare organization. That creates inconsistencies at a national level 
(Ministry of Health & Ministry for Primary Industries, 2017b). Antibiotic use for medicine in 
New Zealand is high in comparison to other countries, with 85-95% of antibiotics dispensed 
within the community and the remaining dispensed through hospital prescriptions (Duffy et al., 
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2018; Williamson, 2016). Between 2004 and 2014, the community-based consumption of 
antibiotics increased by 46% (Williamson et al., 2016). The threat of antibiotic resistant 
pathogens is recognized, however, and through a ‘One Health’ approach, the ‘Antimicrobial 
Resistance Action Planning Group’ with representatives from human health, veterinary health 
and agriculture was created to implement a ‘National AMR Action Plan’ (Ministry of Health & 
Ministry for Primary Industries, 2017b). And although antibiotic resistance frequencies are not 
monitored as regularly as water quality, the Ministry of Health does fund the Institute of 
Environmental Science and Research (ESR) to undertake national AMR surveillance using data 
from various surveillance systems and sources (Ministry of Health & Ministry for Primary 
Industries, 2017b).  
 
On a global scale, antibiotic resistance is also monitored. In 2015, the WHO launched the Global 
Antimicrobial Resistance Surveillance System (GLASS), which was the first system that 
collected resistance data globally from selected human pathogens (World Health Organisation, 
2020c). Their aim is to “..ensure that countries can design cost effective, evidence-based AMR 
response strategies that are prioritized for impact, in the context of whole of society engagement 
across the One Health spectrum.” Networks that contribute data to GLASS include the Central 
Asian and European Surveillance of Antimicrobial Resistance (CAESAR) network, which has 
identified the widespread network of antibiotic resistance, as well as patterns of specific 
resistance in clinical settings (World Health Organisation Regional Office for Europe, 2019) and 
the Centers for Disease and Controls (CDC) who collect health data to monitor the burden of 
antimicrobial resistance on healthcare (Centers for Disease Control and Prevention, 2020). Other 
surveillance networks include the European Antimicrobial Resistance Surveillance Network 
(EARS-Net), which is the largest publicly funded antibiotic resistance surveillance system in 
Europe (European Centre for Disease Prevention and Control, 2020a). This network collects and 
collates temporal and spatial antibiotic resistance data across Europe to inform health authorities 
and to support them in their policy and decision-making surrounding antibiotic resistance. As a 
part of the One Health approach, antibiotic resistance in food-producing animals is also 
monitored. The European Medicines Agency (EMA) works in collaboration with the European 
Food Safety Authority (EFSA) and the ECDC, and it is also involved in the European 
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Surveillance of Veterinary Antimicrobial Consumption (European Centre for Disease Prevention 
and Control. et al., 2017). 
 
The recent COVID-19 pandemic has created further concern surrounding the misuse and overuse 
of antibiotics. Antibiotics have been prescribed to patients who have been infected with SARS-
CoV-2 to prevent or treat bacterial co-infection. A study conducted by the European branch of 
the WHO indicated increased use of antibiotics during the COVID-19 pandemic, with 79-96% of 
uninfected participants taking antibiotics as a preventative measure, and 75% of infected 
participants receiving antibiotics even though only 15% of infected participants developed a 
bacterial co-infection (European Centre for Disease Prevention and Control, 2020b). These 
findings are also supported by Rawson et al. (2020) who identified that 72% of patients 
hospitalised with SARS-CoV-2 infection received broad spectrum antibiotics when only 8% 
were reported to have a bacterial coinfection.  
 
In countries such as the United States, Germany and Italy, increased SARS-CoV-2 and MDR 
bacterial co-infection has been reported (Kampmeier et al., 2020; Nori et al., 2020; Porretta et 
al., 2020; Tiri et al., 2020). However, increased co-infection frequencies were not found in 
France and Spain (Contou et al., 2020; Garcia-Vidal et al., 2021). The overarching concern is 
that antimicrobial stewardship may be undermined due to the continuously increasing workload 
that healthcare workers face during this pandemic, and due to the prioritisation of COVID-19-
related issues (Clancy & Nguyen, 2020). A combination of factors makes it difficult to formulate 
guidelines around the prescription of antibiotics in patients infected with SARS-CoV-2 for either 
prevention or treatment of bacterial coinfection. For one, the reporting methodology of 
microbiological data is inconsistent between countries, and the definitions for coinfection are 
variable, with lack of distinction between infections acquired from the community or from a 
hospital setting (World Health Organisation, 2020b).  
 
The drivers behind antibiotic use are complex and differ by country. The differences in 
consumption of antibiotics can be society-, climate-, and socio-economic group-specific 
(Blommaert et al., 2014; Heinemann & Goven, 2006; Klein et al., 2018; Marra et al., 2010; 
Touboul-Lundgren et al., 2015). For example, where antibiotics can be bought without 
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prescription the antibiotic resistance crisis is much worse (World Health Organisation, 2020a). 
As mentioned earlier, in New Zealand, there are guidelines in place for antibiotic use, however, 
they are specific to each healthcare organisation (Ministry of Health & Ministry for Primary 
Industries, 2017a). This type of organisation may make it difficult to combat antibiotic resistance 
as a nation.  
 
1.3 Sources of AMR in New Zealand 
On a global scale, AMR in New Zealand is low, however, a rising trend in antibiotic resistant 
infections has been observed (Ministry of Health & Ministry for Primary Industries, 2017a). This 
rising trend has been attributed to various causes. The inappropriate use of antibiotics is a 
contributor (Williamson & Heffernan, 2014), as well as transmission of resistant organisms 
within hospital and community settings (Drinkovic et al., 2015; Graves et al., 2003). 
Anthropogenic modification of land has also aided in the distribution of resistant determinants in 
the environment (Asante & Osei Sekyere, 2019). In New Zealand, antimicrobial stewardship 
includes rational use of antibiotics to minimise selective pressure, and to practice effective 
infection control measures (Ministry of Health, 2007a). 
 
According to surveys of sewage systems, New Zealand has one of the lowest levels of antibiotic 
resistance in the world (Hendriksen et al., 2019), however, investigations into other potential 
vectors of antibiotic resistant bacteria have indicated otherwise. Cooke (1976) identified MDR 
coliform bacteria in potable water supplies and discovered that transfer of resistance genes 
occurred within 2 hours of interaction between the MDR bacterium and a susceptible strain. 
Other water sources such as the Waimakariri river (Schousboe et al., 2015), Silverstream and the 
Ōtākaro/Avon river (Adewale, 2018; Van Hamelsveld et al., 2019) have also been found to 
harbour MDR coliforms. Currently, there are no standardised monitoring systems in place that 
specifically observe for antibiotic resistant bacteria within the New Zealand environment.  
 
The use of antibiotics in agriculture and in medicine and veterinary treatment can lead to 
antibiotic resistance in the environment through the excretion of urine and faeces (Figure 1). The 
introduction of antibiotic residues to the environment through waste matter can contribute to 
antibiotic resistant pathogens by creating a fitness advantage for those less susceptible to 
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excreted antibiotics (Lundborg & Tamhankar, 2017; Van Epps & Blaney, 2016). Correlations 
between antibiotic use and the frequency and patterns of resistance in areas impacted by 
anthropogenic activity have been identified (Asante & Osei Sekyere, 2019). The antibiotic 
residues from such activities can be introduced into surface or subterranean waterways through 
urine and waste from livestock or septic tanks or wastewater pipes (Figure 1).  
 
 
Figure 1 The cycle of antibiotic use and the pathway back to humans and animals. 
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1.3.1 Hospital and community 
Transmission of MDR pathogens between people can occur through direct or airborne contact 
(Royal Society Te Apārangi, 2017). This was observed in New Zealand hospitals in the 1950s 
and 1960s, where healthcare workers were unknowingly spreading antibiotic resistant 
Staphylococcus aureus between their patients (Jowitt, 2019). In New Zealand, the three main 
pathogens of concern are community-associated methicillin-resistant Staphylococcus aureus 
(CA-MRSA), Enterobacteriaceae and multidrug-resistant Neisseria gonorrhoeae (The Royal 
Australian College of Physicians, 2016). These organisms are major pathogens in both 
community and hospital settings and are increasingly resistant to major classes of antibiotics 
(Williamson & Heffernan, 2014). The Ministry of Health (2007a) identified that the most 
common mode of transmission of MDR organisms is through healthcare workers, either through 
contamination from an infected patient or through contaminated environmental surfaces. 
Organisms such as MRSA can survive for several months on certain surfaces (Neely & Maley, 
2000). The importance of adhering to cleaning and disinfecting procedures is extremely 
important as a part of antimicrobial stewardship.  
 
1.3.2 Farming and agriculture 
There are several pathways for MDR bacteria to transmit through the environment. Collis et al. 
(2019) found that manure-contaminated pastures, animals, or animal-derived products from dairy 
farms are just some of the pathways through which resistant bacteria transmit. The risks 
associated with antibiotic use in meat production are well known, to the extent that changes in 
policies have been implemented in places throughout Europe and in New Zealand to reduce its 
impact (Heuer et al., 2011; Ministry of Health & Ministry for Primary Industries, 2017b). 
However, other sectors of intensive farming such as dairy farming have not been as well studied. 
Moderate correlations have been found between high intensity farming during winter and 
antibiotic resistant bacteria across twenty freshwater sites within the Southland region 
(Winkworth-Lawrence & Lange, 2016). In comparison to other countries, New Zealand is the 
3rd lowest user of antibiotics in food animals, though this varies on a year-to-year basis and 




The World Health Organisation has created a priority list for human pathogens that include 
ESBL-producing bacteria, which have been known to be associated with dairy cattle and the 
environment (Collis et al., 2019). Agriculture is one of the primary industries in New Zealand, 
with beef, sheep and dairy exports contributing over $23.8 billion towards the economy in 2020 
(Statistics New Zealand, 2020b). In 2018, the Ministry for the Environment had the following 
data on land use in the South Island (Ministry for the Environment, 2018): 
Region 
Dairy farming 
(% of total land area) 
Sheep & beef 
(% of total land area) 
Other livestock 

















Many recreational sites such as Department of Conservation (DoC) camping areas and walks 
have water sources derived from surface waters that run through agricultural areas. The high 
density of land used for farming increases the potential presence of MDR bacteria to which 
tourists and residents may be exposed.  
 
1.3.3 Treated wastewater and irrigation 
Treated wastewater has been found to be a source of antibiotic resistant bacteria. The use of this 
water on land releases resistance genes and antibiotic residues into the terrestrial environment 
(Gatica & Cytryn, 2013; Karkman et al., 2019). Antibiotic resistant bacteria in surface waters are 
frequently linked to wastewater treatment plants (Uyttendaele et al., 2015). Farkas et al. (2016) 
found that MDR bacteria were more prevalent in surface waters than in wastewater. They 
suggested that the bacteria were enriched through wastewater treatment before being released 
into surface waters.  
 
In New Zealand, there are five ways in which treated wastewater is released into the environment 
(Ferguson, 2003): through 
1) freshwater ecosystems (streams, lakes, and wetlands)  
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2) marine ecosystems (estuaries, harbours, and ocean) 
3) land ecosystems (agricultural, horticultural, forestry and landscaped areas)  
4) the atmosphere (i.e., wastewater aerosols)  
5) landfills.   
 
The use of wastewater as irrigation water is a method for conserving potable water. There are 
currently no legal guidelines in New Zealand to regulate antibiotic resistant bacteria in irrigation 
water, with even some untreated wastewater released to the environment through irrigation 
systems (Ferguson, 2003). In New Zealand, irrigation is predominantly used in pastoral farming. 
Between 2002 and 2019 there was a 91% increase in irrigated agricultural land, with largest 
amount of irrigated land found in Canterbury (Statistics New Zealand, 2021). In the Waimakariri 
district, a large proportion of irrigation water is sourced from the Waimakariri river (personal 
communication Waimakariri District Council), a river which has increasingly become 
contaminated with antibiotic resistant E. coli (Schousboe et al., 2015). Without screening for 
antibiotic resistant organisms, treated and untreated wastewater being released into surface 
waters creates a pathway for exposures to antibiotic resistant organisms. The quality of these 
surface waters becomes especially important when they are sourced as drinking and food 
preparation water. Further, the use of water for irrigation which may harbour antibiotic resistant 
bacteria may aid in the spread and dissemination of resistant bacteria and resistant determinants. 
 
1.4 Objectives of this study and hypotheses 
My area of research is on human exposure to water with antibiotic resistant bacteria. The 
objective of this study was to determine the baseline numbers of antibiotic resistant bacteria in 
surface freshwater that is used for drinking and food preparation. The scope was concentrated on 
exposures that would be common for tourists. In part, this was meant to draw attention to the 
difference in potential exposures of tourists and the general domestic population. However, my 
research was not limited to the tourist experience but included local communities near to tourist 
hotspots. 
 
Tourism was one of New Zealand’s largest sectors prior to the COVID-19 pandemic, with 
international and domestic tourism contributing $40.9 billion to New Zealand’s economy 
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annually (Tourism New Zealand, 2020). Many tourists arrive by plane, transit through airports, 
stay in DoC campsites or visit areas where surface water is used for cooking, drinking, and 
swimming. The work begins at the first point of their entry, airplane water, and follows along 
some popular locations around the South Island. The bacterium E. coli was chosen as an 
indicator organism because it is a useful surrogate indicator of faecal presence and disease-
causing organisms in an environment and E. coli levels can be applied to existing guidelines as 
an indicator of human health risk. 
I believe the implications of this research are important as the increase in AMR affects New 
Zealand in multiple ways. Most drinking water in New Zealand is tested but there is a significant 
proportion of water sources that remain untested and unregulated (Ministry of Health, 2019a). 
Along with this, even though current water monitoring reports E. coli levels, it does not include 
screening for antibiotic resistance. There are often warning signs to boil water before 
consumption at sites where the water quality is poor, however, tourists often still wash their 
hands and brush their teeth with the contaminated water, which allows for alternate pathways of 
transmission into the human body.  
1.4.1 Main hypotheses 
Hypothesis 1: Water from the water storage tanks of long-haul international flights will have a 
higher frequency of MDR E. coli than domestic flights within New Zealand. This hypothesis 
would be supported if MDR E. coli were detected in the water. This hypothesis would not be 
supported if there were no difference in MDR E. coli concentrations. 
Hypothesis 2: Tourists will be exposed to more MDR E. coli than recognised because of their 
concentrated experience with water supplies that are rarely or never monitored. This was tested 
by measuring the concentration of both E. coli and MDR E. coli in these water sources. This 
hypothesis would be supported if MDR E. coli were detected in the water. This hypothesis would 
not be supported if MDR E. coli levels were comparable to water supplied and monitored by 
municipalities. 
Hypothesis 3: MDR E. coli isolated from the environment will be able to share resistant 
determinants with susceptible bacteria through horizontal gene transfer. This hypothesis will be 
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supported if resistance is observed in a susceptible lab strain after conjugation experiments. This 
hypothesis would not be supported if sharing of resistance genes is not observed.  
1.4.2 Objectives 
1. Isolate E. coli and antibiotic resistant E. coli from selected surface freshwater that is 
sourced as drinking water across the Marlborough Sounds, Banks Peninsula and Wider 
Canterbury Area using a phenotypic culture-based screening method. 
2. Determine frequency of resistance to eight clinically significant antibiotics using E. coli 
isolates and observing for ESBL-production. 
3. Determine the minimum inhibitory concentration (MIC) of E. coli isolates. 
4. Quantification and comparison of patterns of resistance across different regions. This 
information will allow me to observe whether land use patterns can help to predict 
resistance. 
5. Determine the frequency of resistance genes being carried by conjugative plasmids. 
6. Evaluate the reliability of phenotyping and genotyping using sequenced isolates. 
The study emphasizes geographic range over replication depth. This is because I was trying to 
get an overview of what is present in the water in different locations. Areas that had high E. coli 
counts and MDR E. coli were considered ‘areas of interest’ and were sampled from seasonally to 
observe any changes. Though this research has a broad overview, the primary focus was on 
surface waters sourced as drinking water.  
1.5 Thesis Organization 
Chapter 2 reports on the water quality data from each sampling location, including total E. coli, 
total E. coli resistant to three antibiotics, and total mesophilic bacteria. Chapter 3 investigates the 
resistance profiles of the E. coli isolates, as well as observing for the presence of ESBL-
producing E. coli and conjugative donors. Finally, Chapter 4 discusses the underlying genetic 





Chapter 2: Water quality in the Banks Peninsula, 
Marlborough and Canterbury regions 
Water is both a collector and distributor of microbes. As a collector, it is a like a library with 
individual genotypes representing the outcomes of evolutionary processes in a way similar to 
how books preserve the history of literary thought and record. Water at times can lend members 
of its collection out to us and other water users. Linking the water to the water user through the 
common thread of what microbes they share provides an important framework for my analysis of 
multidrug resistant bacteria in the environment. For my research, the focus is only on the species 
E. coli which is used by me and many others as an indicator of water quality. The additional 
dimension of my work is to also use it as an indicator of antibiotic resistance in the environment. 
Resistant bacteria and resistance genes are ubiquitous in the environment. My focus on E. coli is 
because of my interests are in the increase of number and distribution of these genes. E. coli can 
acquire resistance genes from various pathways in the environment, and these resistance 
determinants can be transferred to human pathogens. Only since the adoption of antibiotics by 
people, and the change in industrial capability to discover, modify and commercialise them 
around the middle of the 20th century, have these genes begun to colonise species such as the 
commensals and pathogens of people. That is why E. coli is a good indicator bacterium for both 
water quality and antibiotic resistance.  
 
In this chapter, I follow the hypothetical journey of a tourist in New Zealand who has arrived on 
an airplane. The microbiological risk from airplane storage tank water from long haul and short 
haul flights are compared. International long haul flights are the first entry point for tourists 
visiting New Zealand, and while they are here, they may catch domestic flights to travel around. 
Next, I follow the tourist who wants to explore the country’s spectacular environment to sites in 
rural areas with different sources of drinking water. Antibiotic resistant bacteria from these 
sources are also compared. Water quality data from sites across the Banks Peninsula, 
Marlborough, and Wider Canterbury area (herein referred to as Canterbury) are used to 
determine whether different regions may have different water quality and try to identify causes. 
Finally, I will present a deeper exploration of the water quality results from a case study 
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observing whether there are seasonal effects on the sizes and densities of E. coli and antibiotic 
resistant E. coli in the rural town of Okains Bay.  
 
2.1 Airplane water 
The water storage tanks in airplanes potentially harbour multidrug resistant bacteria. The supply 
chain journey from the water source to the water service vehicle to the airplane water storage 
tank can be an enriching environment for bacteria. A 2003 study by the Association of Port 
Health Authorities and the Public Health Laboratory Service in the United Kingdom found that 
coliform contamination in airplane storage tanks was strongly associated with the supply chain 
(Nichols, 2003). The water tanks on planes are rarely emptied or cleaned; they are only emptied 
when the water on board has been entirely consumed or when the aircraft is not in operation 
(Handschuh et al., 2015). According to media sources, in 2004 the United States Environmental 
Protection Agency found that 15% of samples from 300 planes contained coliforms (Gajanan, 
2017). This becomes a larger issue when the quality of the water source is poor. Nichols (2003) 
showed that variation in coliform contamination was associated with particular airports, 
indicating poor water quality from the sources. For example, the well at Christchurch 
International Airport has a microbial water quality grade of ‘D’, which means that it has an 
unsatisfactory level of risk for use as potable water (Institute of Environmental Science and 
Research, 2021). If this water is used to refill the water storage tanks in airplanes, it could 
present further risk of exposure to harmful bacteria that are antibiotic resistant. Because this is 
the main passage for most tourists into our country, it is important to investigate the risks that 
may stem from these exposures. Though water on airplanes is not commonly used for drinking 
water, there are other pathways that people interact with this water that exposes them to risk of 





Figure 2 Risk analysis of exposure, pathways, and infection from antibiotic resistant organisms. 
 
2.2 Surface waters that are sources of drinking water 
Water recreational activities are an important part of the local culture and lifestyle in New 
Zealand, and prior to the COVID-19 pandemic, were significant also to tourists. Such activities 
are concentrated in the summer months when access to potable water is particularly important. 
Potable, recreational, and grey water must all meet different standards (Table 1). In New 
Zealand, all potable water must meet the minimum quality standards for drinking water as 
outlined by the Ministry of Health and the New Zealand Drinking Water Association (Ministry 
of Health, 2018). The Drinking Water Standards for New Zealand (DWSNZ) outlines the 
maximum acceptable value for E. coli is less than 1 in 100 mL of sample for drinking water 
(Ministry of Health, 2018). Most water supplies are monitored, though even not all of these must 
be reported (Institute of Environmental Science and Research, 2021). Water quality monitoring, 
especially in rural areas, helps to identify causes of contamination, and regular monitoring 




Table 1 Water quality required for different household activities. Table sourced from Ministry of Health (2007b). 
Type of use Quality requirements 
Drinking, cooking, food preparation  Biologically and chemically safe 
Bathroom Biologically safe, chemically safe for skin contact 
Laundry, toilet flushing  Should not cause stains or damage clothing 
Outdoor (eg, irrigation, car washing)  No special requirements but safe for skin contact 
 
Surface waters are commonly used for drinking water in New Zealand. If they are distributed in 
a distribution zone, then treatment occurs at the plant to ensure the potable water is compliant 
with the DWSNZ. However, the DWSNZ does not require compliance for private distributions 
or reticulated town supplies for fewer than 1,500 person days (ie., 25 people for fewer than 60 
days) (Ministry of Health, 2017). Surface waters in rural areas where campgrounds and small 
rural communities are based are likely to fall under these categories. These places are generally 
affected by human activity, and the surface waters are highly likely to be contaminated by animal 
waste, sewage effluent and agricultural fertilisers (Ministry of Health, 2017). Rivers and streams, 
which are some of the surface sources which my thesis focuses on, often have poor water quality, 
and may be contaminated by wildlife, farm animals, decaying vegetation, algae, wastewater, and 
other human inputs (Ministry of Health, 2007b). Table 2 describes the common causes of 
contamination in surface waters and their likely sources. The Ministry of Health suggests treating 
noncompliant raw water with chlorine dosing, ultraviolet (UV) light treatment, boiling or 
chemical treatment in order to meet the minimum requirements for safe drinking water (Ministry 




Table 2 Common causes of contamination in surface waters and their sources. Sourced from Ministry of Health 
(2017). 
Cause Problem Likely Source 
Bacteria Waterborne disease  Human and animal 
wastes 
Nitrate Bottle fed infants can have breathing problems (blue baby 
syndrome)  
Fertilisers, sewage, 
animal effluent, clover 
pasture 
pH When less than 6.5, corrosion of plumbing materials, 
possibly causing copper or lead to be dissolved into the 
water 
Soft water, CO2 rich 
groundwaters 
 When greater than 8.5, scale formation in hot water 
cylinders and on heating elements causing reduced 
efficiency and premature failure. Also, can cause 
excessive scale build-up in pipes 
Many groundwaters 
Protozoa  Waterborne disease  Human and animal 
wastes 
Turbidity Appearance, and interference with disinfection Suspended particles of 
natural and human or 
animal origin 
Viruses Waterborne disease Human and animal 
wastes 
 
Phiri et al. (2021) performed a survey of 15 public DoC campgrounds in New Zealand. They 
measured E. coli as an indicator of drinking water quality. The sites were supplied by water 
collected from roofs or surface water for their drinking water, and a mixture of water quality 
treatments from none to UV irradiation, filter filtration, chemical treatment, or a combination of 
the last three. In more than 50% of sampling occasions, the drinking water was not compliant 
with the national standards. Their findings highlighted the importance of proper water treatment, 
as the use of water filters alone was not sufficient to provide safe drinking water. Rather, the use 
of UV treatment alone, or in conjunction with chemical treatment, was necessary to provide 




Users must be warned when the water available at these campsites and outdoor recreational areas 
do not meet the DWSNZ minimum requirements. This is generally done through a ‘Boil Water 
Notice’ sign. This sign warns users to boil the water for at least three minutes before consuming 
to minimize the potential risk posed by the contaminated water. The risk of infection by an 
antibiotic resistant organism arises from exposure to water contaminated with them. Even if the 
water is not immediately safe to drink, it could be used for hygiene purposes such as showering, 
hand washing and even cleaning teeth. Access through ingestion or through open wounds can 
lead to serious infections (Figure 2). As antibiotic resistance in the New Zealand environment 
grows, so does the risk of being infected by an antibiotic resistant organism. 
 
2.3 Case study: Okains Bay 
Okains Bay was selected as a case study for my thesis because it is a good example of a small 
rural community that sources their drinking water from a surface water that is non-compliant 
with DWSNZ. Okains Bay is a rural town in the Banks Peninsula area in the South Island. It has 
a population of approximately 105 people (Institute of Environmental Science and Research, 
2021). Around 100 residents (40 households), and the Christchurch City Council-owned 
campground, are involved in a private scheme organized by the Okains Bay Water Committee to 
source drinking water from the nearby Opara Stream (Law, 2018). The Opara Stream, however, 
does not meet the DWSNZ, and requires at least boiling before it is considered potable (Institute 
of Environmental Science and Research, 2021). Other residents’ source their drinking water from 
nearby tributaries that feed into the Opara Stream, or from the aquifer that is the source of the 
Opara Stream (personal communication with residents). Many of the residents fill up large 
containers of clean drinking water from Akaroa or Christchurch or buy bottled water (Law, 
2017). Residents pay $30 a year for maintenance, while the Okains Bay School spends over 
$1,000 a year for water quality testing and filtration systems to provide the school children and 
the staff safe drinking water (Law, 2017). However, the filtration systems at the schoolhouse 
does not consistently provide clean water, leaving the staff and children exposed to untreated 
water (private communication with the school’s principal). In 2020, the school moved into a new 
building, with updated filtration systems. Through communications with the principle, I was 
informed that the treatment systems at the new school were sufficient for the drinking water to be 
compliant with DWSNZ standards. Okains Bay is a catchment area, and the water quality is 
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influenced by rainfall. Faecal contamination of the Opara stream can occur from the runoff from 
land grazed sheep, cattle, septic tank seepage, and even from runoff from roofs (Bolton-Ritche, 
2008).  
 
2.4 Main hypotheses 
Hypothesis 1: Water from the water storage tanks of long-haul international flights will have a 
higher frequency of E. coli than domestic flights within New Zealand.  
Hypothesis 2: Antibiotic resistant E. coli will be found in areas with water supplies that are 
rarely or never monitored but are high in visitation by tourists. This was tested by measuring the 
concentration of both E. coli and resistant E. coli in these water sources.  
Hypothesis 3: E. coli concentrations will be predictive of resistant E. coli.  
My first hypothesis was tested by observing the water quality of airplane water, using E. coli as 
an indicator, and comparing the E. coli concentrations between short domestic flights and long-
haul flights. My second hypothesis was tested by observing the quality of drinking water across 
the Canterbury, Banks Peninsula and Marlborough regions using E. coli as an indicator and 
comparing the antibiotic resistant E. coli and mesophile profiles between sites. Sites were 
selected based on their source of drinking water. My final hypothesis will be tested by observing 









2.5 Sampling Locations: Airplane Water 
Airplane water samples were gathered when opportunities to do so arose.  Samples were 
obtained from volunteers among acquaintances and family members who were traveling on 
either domestic or international flights. Table 3 details a list of the flights and the airlines. 
 
Table 3 Departure and arrival locations for airplanes included in the water quality study. 
Departing Location Arrival Location Airline Date 
Fiji NZ Air New Zealand 8th May 2019 
Abu Dhabi Sydney Emirates 5th April 2019 
Sydney Christchurch Emirates 5th April 2019 
Rarotonga Auckland Air New Zealand 17th May 2019 
Rotorua Christchurch Air New Zealand 20th April 2019 
Dunedin Christchurch Air New Zealand 2nd June 2019 
Auckland Christchurch Air New Zealand 21st July 2019 
Auckland Christchurch Jetstar 20th October 2019 
 
2.6 Sampling Locations: Drinking Water Samples 
Samples were obtained from selected rural campgrounds and outdoor recreational areas in the 
Canterbury, Banks Peninsula and Marlborough regions. These areas were chosen because they 
have a high volume of tourist traffic and it is common for fresh surface water to be sourced as 
drinking water. Specific locations were chosen through advice from the Renwick Department of 
Conservation (Renwick DoC), Councillor Lan Pham from Environment Canterbury (ECan) and 
through personal investigation. Drinking water samples were split into three categories: Treated 
vs Stream vs Other. The category Treated includes water that is sourced from surface waters but 
is treated locally to provide potable water for users. The category Stream represent sites where 
the drinking water is sourced untreated from streams. The category ‘Other’ includes untreated 
water sources such as tributaries, rivers, and springs which were included less frequently in my 
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Sampling Location Area Water supply 




Leeston Water supply not suitable for 














Kaikoura Boil water notice. Drinking water 
comes from a stream which runs 
through Goose Bay Camp. It is 
diverted to a pump and filtration 
facility for distribution to all 
camps. The water is tested 
regularly, and its current status is 
that it is safe to drink (personal 
communication with Kaikoura 





Rakaia Huts Camping 
Ground 
Rakaia Town reticulated supply. 1 
Sharplin Falls Carpark Mount 
Somers 
Sourced from stream. All drinking 
water in this area should be 
sterilised, filtered or boiled for 3 





2.6.2 Banks Peninsula 
Sampling 







Treated through a private system. Water 




 Untreated. This is the source of drinking 
water for the campground. 
1 




These are the sources of drinking water for 
Little River. Water is treated before 
distribution. 
1 
Okains Bay Banks 
Peninsula 
I had seven sampling sites in the Okains Bay 
area. The approximate location of each site 




Site 1: Upstream 
 
This site is approximately 5.3 km upstream of the estuary. It 
runs through a farm parallel to Okains Bay Road 
 
Site 2: Tributary This site is approximately 5.3 km upstream of the estuary. This 
tributary travels under the Okains Bay Road and feeds into the 
‘Upstream’ site. 
Site 3: Whitebait Bridge This site is approximately 2.8 km upstream of the estuary. This 
bridge connects Okains Bay Road to Okains River Road and 
Schoolhouse Road. The Opara Stream runs parallel to Okains 
Bay Road approximately 1.5m away from the road. At this site, 
the Opara Stream is flowing through the township. 
Site 4: Okains Bay School 
 
This site is approximately 2 km upstream of the estuary. The 
sample was taken from the kitchen tap in the school.  
Site 5: Okains Bay 
Campground Kitchen 
 
This site is approximately 0.25 km upstream of the estuary. This 
is one of two kitchens at the Okains Bay Campground, however, 
the other kitchen was closed for maintenance during sampling. 
Site 6: Estuary  This site is where the Opara Stream meets the South Pacific 
Ocean. The estuary has open access to campers and visitors.  
Site 7: Residential Home 
 
The drinking water from this residential home is sourced from a 
tributary that feeds into the Opara Stream. The water samples 






Figure 3 Sampling sites from Okains Bay: 1. Upstream; 2. Tributary; 3. Whitebait Bridge; 4. Okains Bay School; 5. 






Location Area Water supply 




Waikawa Boil water notice. Water 
sourced from Pukatea 
awa/stream. Information 




Rarangi Water supplied by North 
Rarangi Water Supply Inc, 
reticulated town supply. 





Lake Grassmere Boil water notice. Water 
supplied by Marlborough 
District Council from the Black 
Birch River water supply for the 
lower Awatere Valley. 







Boil water notice. Spring water 





2.7 Sampling Methods 
2.7.1 Airplane Water 
At least 100 mL of water was collected from the sink in the airplane toilet. Where possible, 
samples were kept cool (at ambient cabin temperature) and were processed as soon as they 
arrived. For domestic flights, 50 mL sterile falcon tubes were used for water collection. For long 
haul flights, unopened bottles of water were used, and the seal was broken, and water emptied 




2.7.2 Drinking Water  
1. Personal Collection 
At least 800 mL of water was collected in 1 L sampling bottles from each sampling site, with 3 
replicates for each location. The bottle was only opened immediately prior to gathering the 
sample to maintain the sterility of the bottle. The temperature and pH of the water was also 
taken.  
 
2. Samples by courier 
At least 800 mL of water was collected in 1 L sampling bottles from each sampling site with 3 
replicates for each location. Sample gatherers were advised to wear gloves and only open the 
bottle immediately prior to gathering the sample to maintain the sterility of the bottle. They were 
instructed to record the time the sample was taken (and temperature if possible) and to send the 
samples on the same day in a freezer box with ice packs.  
 
2.8 Culturing methods 
2.8.1 Airplane Water 
For airplane water samples, either 50 mL or 100 mL was filtered and placed onto TBX (Tryptone 
Bile Glucuronic agar; Himedia) only. 100 µL was spread plated onto R2A (Reasoner’s 2A agar; 
Difco). Plates were incubated 18 h with plates selective for E. coli incubated at 44°C and plates 
permissive for mesophilic bacteria incubated at 30°C.  
 
2.8.2 Drinking Water 
100 mL of the samples were filtered through Büchner funnels onto 0.45 µm nitrocellulose filters 
(Merck Millipore) and the filters were placed onto TBX, TBX supplemented with ampicillin (8 
μg mL−1), ciprofloxacin (1 μg mL−1) and chloramphenicol (8 μg mL−1). Along with the four 
plates, 1 ml of the sample was spread plated onto TBX, and 100 µL onto R2A for observation of 
mesophilic bacteria. Plates were incubated 18 h with plates selecting for E. coli incubated at 
44°C and plates permissive for mesophilic bacteria incubated at 30°C.  
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2.9 Toothbrush experiments 
I was interested in observing whether E. coli in the water could survive on toothbrush heads. To 
test this, an exploratory study was conducted investigating three different methods of water 
exposure, and the differences between using toothpaste and not using toothpaste (Table 4). Full 
immersion involved soaking the toothbrush head in the water completely, aerosol involved 
spraying the water on the toothbrush head and consistent flow involved pouring water over the 
toothbrush head to mimic water coming out of a tap. 50 mL of water sampled from Okains Bay 
Campground Kitchen was used for each condition, and sterilized distilled water was used as a 
negative control. The initial E. coli concentration in the water from Okains Bay Campground 
Kitchen was determined to be 8 x 101 cfu mL-1. Each condition was tested in triplicates and 
repeated with dilutions up to 1 x 10-2 cfu mL-1. After incubation, the toothbrush heads were 
immersed in 25 mL of sterilized water and vortexed for 30 sec, sonicated for 5 min, and vortexed 
for 30 sec again to detach any E. coli. 20 mL was filtered onto TBX and 1 mL was spread plated 
onto TBX. Immersion in Luria-Bertani (LB; Invitrogen) agar was employed to observe E. coli on 
the toothbrush head. This study was based on Kobayashi et al. (2009) with modifications.  
 
Table 4 Different methods of water exposure on toothbrushes with and without toothpaste. 
Method Condition Time (h) 
Full immersion Toothpaste 18 
 No toothpaste 18 
Aerosol Nil 18 
Consistent flow Toothpaste 3 
 No toothpaste 3 
 Toothpaste 6 
 No toothpaste 6 
 Toothpaste 18 




2.10 Statistical analysis 
R was used for all statistical analyses in this thesis (R Core Team, 2020). Plots of residuals were 
used to check for violations of assumptions in all analyses. In all cases, the assumption of 
normally distributed residuals was violated, even after log transformation. To handle this, 
generalized linear models (GLM) and generalized linear mixed models (GLMM) were 
employed. Distribution of residuals from the models were investigated to observe whether the 
residual structure fit the assumptions made in the model.  
 
2.10.1 Airplane water 
For the airplane storage tank water, I was interested in the difference in microbial load between 
long haul and domestic flights, and whether there were differences between the airlines. In total, 
eight flights were included in the analysis (four long haul, four domestic) from three different 
airlines; Air New Zealand (ANZ), Emirates and Jetstar. A generalized linear model (GLM) with 
a Poisson log link was chosen as the mesophilic bacteria counts followed a Poisson distribution, 
and residuals were not normally distributed.  
 
2.10.2 Drinking water 
Across the three regions, I was interested in whether E. coli abundance and resistant E. coli 
abundance was dependent on the water source, and whether there were differences across the 
regions. In total, 12 sites with 3 replicates per site across the Banks Peninsula, Marlborough and 
Canterbury region were chosen for analysis (Table 5). Counts of mesophilic bacteria were 
always above the detection limit. A generalized linear mixed model (GLMM) with a Poisson log 
link was chosen as the E. coli per 100 mL counts followed a Poisson distribution, the residuals 
were not normally distributed, and the water sources categories were unbalanced. Over 
dispersion was accounted for by assigning each observation a unique value and including this as 
a random effect in the analysis.  
 
A GLMM with a Poisson log link model was selected for the ampicillin resistant E. coli 
populations, for the same reasons as the analysis for the total E. coli counts per 100 mL. Over 
dispersion was accounted for by assigning each observation a unique value and including this as 
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a random effect in the analysis. For E. coli resistant to chloramphenicol or ciprofloxacin, often 
counts were below the detection limit. Due to this, a GLMM with a binomial link was selected. 
 
I was interested in whether the total E. coli counts per 100 mL could be predictive of resistant E. 
coli populations. To determine this, a linear regression was performed on log transformed total 
E. coli counts and resistant E. coli counts. This analysis was limited to ampicillin resistant 
populations as ciprofloxacin resistant and chloramphenicol resistant counts were often below the 
detection limit. A small constant of 0.0001 was added prior to log transformation, and 
observations where E. coli counts were below the detection limit were omitted from the analysis.  
 
Table 5 Sites included in the drinking water GLMM analysis. 
Location Site Water source 
Banks Peninsula  Residential Okains August Other 
Okains Campground Kitchen Stream 
Okains School Stream 
Little River Campground Treated 
Marlborough Marfells Beach Campsite Other 
Whatamango Bay Campground Other 
Whites Bay Campground Stream 
Rarangi campground Treated 
Canterbury Lakeside Domain Other 
Sharplin Falls Stream 
Omihi Campground Treated 
Paia Point Campground Treated 
 
2.10.3 Okains Bay 
Across all six sites, I was interested in whether E. coli, resistant E. coli and mesophilic bacteria 
abundance was dependent on the site, and whether there were differences across four seasons. 
All 6 sites across four seasons were included in the analysis, except for one site (Okains Bay site 
1, tributary) in autumn as the tributary was too low to obtain an adequate sample. This sample 
was omitted form the analysis. Counts of mesophilic bacteria were always above the detection 
limit. To compare differences between seasons, a GLMM with a Poisson log link was chosen for 
the E. coli analysis, the ampicillin resistant E. coli analysis and the mesophilic bacteria analysis 
as the bacterial counts followed a Poisson distribution, the variance was not normally distributed, 
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and the categories were unbalanced. Over dispersion was accounted for by assigning each 
observation a unique value and including this as a random effect in the analysis. For E. coli 
resistant to chloramphenicol or ciprofloxacin, often counts were below the detection limit. Due 
to this, a GLMM with a binomial link was selected.  
 
To compare differences between sites in each season, a GLM with a Poisson log link was 
selected as was chosen for the E. coli, the ampicillin resistant E. coli, the chloramphenicol 
resistant E. coli and the ciprofloxacin resistant E. coli analysis as the E. coli per 100 mL counts 
followed a Poisson distribution and the variance was not normally distributed. Chloramphenicol 
resistant E. coli were below the detection limit in all seasons except spring, therefore the analysis 
was only done for this season. Similarly, ciprofloxacin resistant E. coli were below the detection 








2.11 Airplane Water 
Mesophilic bacteria were detected at 103 cfu mL-1. E. coli was always below the detection limit. 
Long haul flights had significantly more mesophilic bacteria than domestic flights (p <0.0001). 
ANZ and Emirates both had significantly more mesophilic bacteria than Jetstar (p < 0.0001). 
Details from the statistical analysis can be found in Appendix A1. 
 
2.12 Water Quality Results: Total E. coli and mesophilic bacteria 
A summary of the water quality results can be found at the end of this section in Table 6. 
Mesophilic bacteria were detected at 102 to 104 cfu mL-1. Treated had significantly lower 
mesophilic bacterial numbers than Stream and Other (p <0.0001). Banks Peninsula had 
significantly more mesophilic bacteria than Canterbury (p <0.0001), and Canterbury had 
significantly higher mesophilic loads than Marlborough (p <0.0001).  
 
The total E. coli count varied between 100 and 5 x 102 cfu 100 mL-1 across the three conditions. 
There was a significant difference between Treated and Stream (p = 0.001), and no significant 
differences between Treated and Other (p = 0.053) or Stream and Other (p = 0.3940). There were 
no significant differences in E. coli counts between regions, however, within Canterbury, there 
was significantly more E. coli in Stream than in Treated (p < 0.046; Appendix A2). The highest 
E. coli count was detected at Site 11 in Canterbury (source = Stream), while the lowest E. coli 
counts were detected in both Other and Treated water sources across the three regions. Figure 4 











Boxplot of E. coli distribution across the water sources and regions 
 
Figure 4 Distribution of E. coli across Other, Stream and Treated across the three regions. Banks = Banks 
Peninsula; Cant = Canterbury; Marl = Marlborough Sounds. 
 
2.13 Distribution of ampicillin resistant populations across water sources 
There were significant differences in ampicillin resistant E. coli concentrations between Treated 
Stream (p < 0.0184). Other in Banks Peninsula had significantly higher numbers of ampicillin 
resistant E. coli than Treated in Canterbury (p = 0.0027). Within Canterbury, there was 
significantly more resistant E. coli in Stream than in Treated (p < 0.0064; Appendix A3). 
 
2.13.1 Are E. coli population densities predictive of antibiotic resistant population 
densities? 
Following from Van Hamelsveld et al. (2019) I wanted to investigate whether total E. coli counts 
could be predictive of resistant populations in the environment. Ampicillin resistant populations 
were selected for this analysis. There was no association between total E. coli counts per 100 mL 




Figure 5 The relationship between total E. coli and ampicillin resistant E. coli per 100 mL. No correlation was 
found (R2 = 0.0385). 
 
2.14 Distribution of chloramphenicol resistant and ciprofloxacin 
resistant populations across water sources 
There were no significant differences in chloramphenicol resistant E. coli populations across the 
three water sources or the three regions (Appendix A5). There were no significant differences in 
ciprofloxacin resistant E. coli populations across the three water sources or the regions 
(Appendix A4). Of the sites included in this analysis, chloramphenicol resistant and 
ciprofloxacin resistant E. coli populations were only detected on two sampling occasions, and in 
one instance, ciprofloxacin resistance was just above the detection limit.   
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Table 6 Summary of results (p values) from the water quality analysis. Comparisons between water sources, and 
between regions. * = significant difference; AmpR = ampicillin resistant; ChlR = chloramphenicol resistant; CipR = 
ciprofloxacin resistant; BP = Banks Peninsula; C = Canterbury; M = Marlborough. 
Comparisons Total E. coli AmpR E. coli ChlR E. coli CipR E. coli 
Mesophilic 
bacteria 
Other – Stream 0.3940 0.6062 1 1 0.7444 
Other – Treated 0.0534 0.1380 1 1 <0.0001* 
Treated - Stream 0.0016* 0.0184* 1 1 <0.0001* 
BP – C 0.4670 0.1523 1 1 <0.0001* 
BP – M 0.6850 0.0986 1 1 0.0930 
C - M 0.9276 0.1244 1 1 <0.0001* 
 
2.15 Okains Bay  
2.15.1 Seasonal effects 
Mesophilic bacteria were detected at 100 to 103 cfu mL-1 and varied significantly between 
seasons (p <0.0001). Summer samples had significantly more mesophilic bacteria than the other 
seasons (p <2e-16). Figure 6 compares the distribution of E. coli and resistant E. coli across the 
six sites and four seasons. E. coli concentrations in the water were 100 to 103 cfu mL-1. Post hoc 
analysis revealed significant differences between winter and autumn (p = 0.0242) and autumn 
and summer (p <0.0001). Overall, the highest E. coli concentrations were detected in summer. 
Detailed statistical outputs can be found in Appendix A6. 
 
Ampicillin resistant E. coli concentrations in the water were between 100 and 102 cfu 100 mL-1 
and varied significantly between seasons (p <2e16). Post hoc analysis revealed significant 
differences between winter and autumn (p = 0.242), and autumn and summer (p <0.0001). 
Ampicillin resistant populations were detected in all seasons except autumn, and concentrations 
varied across sites. Detailed statistical outputs can be found in Appendix A7. Chloramphenicol 
resistant E. coli was below the detection limit in all seasons except spring, however, this 
detection was not significant. Ciprofloxacin resistant E. coli was below the detection limit in all 





Figure 6 Log distribution of E. coli across four seasons in Okains Bay. AmpR = ampicillin resistant; ChlR = 
chloramphenicol resistant; CipR = ciprofloxacin resistant; T = Tributary; U = Upstream; B = bridge; S = 




2.15.2 Difference across sites 
Overall, during the winter season there was a downward trend in E. coli counts going from 
upstream to downstream (site E) with the most upstream site (U) harbouring significantly more 
E. coli than the most downstream site (E; p < 0.0001). Ampicillin resistant E. coli followed the 
same trend with the exception of site T which had the lowest ampicillin resistant counts across 
the sites. The most upstream site had significantly more E. coli than the most downstream site (p 
< 0.0001). Chloramphenicol and ciprofloxacin resistant E. coli were below the detection limit in 
winter. The statistical output from the GLM with differences between each site can be found in 
Appendix A8. 
 
During the spring season, site T was too low to sample from. This site was omitted from the 
analysis. All sites had significantly different E. coli counts from each other (p < 0.0001). For 
both E. coli and ampicillin resistant E. coli, concentrations appear to increase from the most 
upstream site to the schoolhouse (S) before dropping significantly at site K and increasing again 
at site E (Figure 6). Chloramphenicol resistant E. coli was detected at sites U, B and S, with E. 
coli counts increasing going from upstream to downstream. Ciprofloxacin resistant E. coli were 
below the detection limit in spring. The statistical output from the GLM with differences 
between each site can be found in Appendix A9. 
 
During the autumn season, the schoolhouse had relocated to a new building and the sample 
obtained from the old schoolhouse was inadequate, so this site was omitted from the analysis. All 
sites had significantly different E. coli counts from each other (p < 0.0001), apart from sites B 
and U. Like the spring season, E. coli and ciprofloxacin resistant E. coli concentrations increased 
going downstream until decreasing significantly at site K. Chloramphenicol and ampicillin 
resistant E. coli were below the detection limit in autumn. The statistical output from the GLM 
with differences between each site can be found in Appendix A10. 
 
During the summer season, the E. coli concentrations generally decreased from upstream to 
downstream. All sites had significantly different E. coli counts from each other (p < 0.0001). 
Ampicillin resistant E. coli concentrations significantly increased going downstream until site S, 
before decreasing towards site E. Chloramphenicol and ciprofloxacin resistant E. coli were 
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below the detection limit in summer. The statistical output from the GLM with differences 
between each site can be found in Appendix A11. 
 
2.16 Can E. coli persist on toothbrushes? 
There were no significant differences between the methods of water exposure. There was no 
significant difference between the toothpaste and no toothpaste conditions.  E. coli was only 
detected on the toothbrushes when they were embedded in agar immediately after exposure to 
the water and was only detected in the full immersion and aerosol methods. The E. coli counts 
detected were always below 10 cfu 20 mL-1. In the consistent flow method, E. coli was below the 
detection limit at all time points (3, 6 and 18 h). Figure 7 shows the E. coli growth from when the 
toothbrushes were embedded in agar immediately after exposure to the water. 
 
 
Figure 7 Toothbrush heads which were immediately embedded in TBX agar after exposure to Okains Bay 
campground water through the aerosol method. E. coli colonies are blue. A) Shows dispersal of E. coli like 
associated with excess water on the toothbrush head. B) E. coli colony embedded within the toothbrush bristles and 




The airplane water storage tank analysis revealed that water from airplanes on long haul flight 
routes had significantly higher mesophilic bacterial concentrations than planes on domestic 
routes. E. coli concentrations were always below the detection limit. The limiting factor of this 
study was obtaining water samples from airplanes. Domestic flight samples were predominantly 
from main cities, which limited the analysis to similar size planes and may not have captured the 
true scope of microbiological quality in domestic aircrafts within New Zealand. Samples from 
long haul international flights were difficult to obtain, and in 2020 it was no longer an option, 
which limited the total number of samples obtained from long haul flights to only four. However, 
the difference observed in my analysis supports findings from Handschuh et al. (2015) who also 
identified that the water in planes used for long haul flights had poorer microbiological quality 
than short haul flights. The results from this analysis do not support my first hypothesis, as no E. 
coli were detected in either long haul or domestic flights. Without identifying the isolated 
bacteria, it is difficult to accurately compare the risk presented by the water from either long haul 
or domestic flights. This would be the next step if this analysis were done in the future. 
Techniques such as metabarcoding may be a good option for this. 
 
Overall, the results from the water quality analysis showed that Treated had significantly lower 
E. coli concentrations and ampicillin resistant E. coli concentrations than Stream. E. coli 
concentrations in water from the three regions were not significantly different, however, there 
were significant differences within Canterbury. Mesophilic bacterial counts were significantly 
lower in Treated and had the highest counts in Banks Peninsula and the lowest in Marlborough 
(Table 6).  
 
The significant differences in E. coli and ampicillin resistant E. coli between Treated and Stream 
supports other findings that robust water treatment systems need to be in place to ensure that 
potable water is available (Phiri et al., 2021). This result partially supports my second 
hypothesis. For my hypothesis to be fully supported, I would have expected Other to harbour 
significantly more E. coli than Treated. The category Other included sources such as tributaries, 
rivers and springs, all of which had varying concentrations of E. coli. This category was created 
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because those sources were not sampled as frequently as Treated or Stream. Sources such as 
springs may not be subjected to the same anthropogenic impacts as rivers or tributaries, so the 
representation in this category may be skewed. There were no significant differences in E. coli 
counts between the three regions. The sites in the Banks Peninsula region were located in heavy 
agricultural areas with farming in the catchment area. Some of the sites were in small rural 
communities which were geographically distant from main townships and were likely to have a 
poor infrastructure for their drinking water and waste treatment. Water quality in this region has 
been previously identified as not meeting DWSNZ standards. The sites in the Canterbury region 
were all relatively close to a township (either Kaikoura or Christchurch), except for the Sharplin 
Falls car park site. This site had the highest E. coli concentration across all the sites in 
Canterbury. This site is in close proximity to Mt Somers station, which is a 3800 ha farm which 
farms sheep, deer and dairy and beef cows. In the Marlborough Sounds, the sites were all along 
the East coast of the Marlborough region, and were in close proximity to a township (either 
Blenheim or Picton). These sites are in a mixture of agriculture and forestry-based use areas, 
however, the Canterbury area (including Banks Peninsula) has more than four times the land use 
for agriculture (Ministry for the Environment, 2018). The sites Whites Bay and Whatamango 
Bay have previously been a part of a water quality study which also found that the E. coli 
concentrations in the drinking water were non-compliant with DWSNZ (Phiri et al., 2021). My 
findings were similar, with both sites consistently non-compliant with DWSNZ over multiple 
sampling events. The lack of significant differences between the water sources between regions 
may indicate that each region is subjected to its own influences of E. coli and resistant E. coli 
contamination. 
 
Ampicillin resistant E. coli were the most consistent resistant populations detected across the 
sites and were detected at a much higher frequency than chloramphenicol and ciprofloxacin 
resistant E. coli. This aligns with Van Hamelsveld et al. (2019) and Adewale (2018) who found 
also found ampicillin resistant populations at a higher frequency than chloramphenicol and 
ciprofloxacin resistant populations in rural surface waters. The consistent detection of ampicillin 
resistant E. coli populations in this study was not surprising. Penicillin is one of the largest 
classes of antibiotic used in agriculture and veterinary medicine, with predominant use in cattle 
followed by companion animals (New Zealand Food Safety, 2020), and it is the most common 
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antibiotic used in dairy and meat production (Bryan & Hea, 2017). Ampicillin resistant E. coli 
were detected at sites that were in areas with heavy agricultural influences. I wanted to observe 
whether total E. coli could be predictive of resistant populations in the environment. Ampicillin 
resistant populations were selected for this analysis as it was the most consistent resistant 
population detected. This relationship has relevance for water quality monitoring as currently, 
antibiotic resistant populations are not monitored in the environment. If E. coli concentrations 
were predictive of resistant populations, it provides another dimension to water quality 
monitoring, where resistance information could potentially be extrapolated from total E. coli 
counts. Unfortunately, total E. coli concentrations was not predictive of ampicillin resistant 
populations. This means that total E. coli could not be used as a predictor of resistance in the 
environment. Ampicillin resistant E. coli were significantly different between Treated and 
Stream. In most cases, ampicillin resistant populations were identified at sites where the drinking 
water was sourced from Stream or Other and in agricultural areas.  
 
Chloramphenicol resistant populations were only identified in one sampling event; however, this 
detection was not significant. In New Zealand, the use of chloramphenicol to treat bacterial 
infections in food producing animals is not permitted (New Zealand Food Safety, 2018). It is 
predominantly used to treat bacterial conjunctivitis in humans and in companion animals (Health 
Navigator, 2017; New Zealand Veterinary Association, 2018b; Ponen, 2019a). Though the use of 
chloramphenicol in New Zealand is limited to human and veterinary medicine, resistant 
populations still exist in the environment even if my analyses detected them infrequently. 
Chloramphenicol resistance in aquatic environments could be due to genes conferring resistance 
being shared with other bacteria in the environment, co-selection or cross-resistance or due to 
multidrug efflux pumps in bacterial systems (Yoo et al., 2003).  
 
Interestingly, ciprofloxacin resistant populations were only identified during one sampling period 
in the Banks Peninsula region (May 2020). The most significant event which occurred at the time 
was the nation-wide lockdown due to the COVID-19 pandemic. Ciprofloxacin is secreted 
through urine, with 50-70% excreted unchanged. This may be a source for chemical selection of 
ciprofloxacin resistant E. coli as a result of the month-long lockdown posing a heavier burden on 
septic tanks in the rural community. However, without having samples from right before the 
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lockdown period, it is difficult to infer that this was the cause.  In 2014, ciprofloxacin was one of 
the top ten most consumed antibiotics in human healthcare in New Zealand (Williamson et al., 
2016). It is also used to treat infections in companion animals and in agriculture (Ministry for 
Primary Industries, 2005). Its use is widespread in New Zealand. 
 
In Okains Bay, there were significant seasonal effects on mesophilic bacteria, E. coli and 
ampicillin resistant E. coli. Autumn had significantly fewer E. coli and ampicillin resistant E. 
coli than winter and summer (p < 0.0001). Winkworth-Lawrence and Lange (2016) had 
previously detected correlations between high intensity farming in winter and antibiotic resistant 
bacteria. This reason may account for the high E. coli and ampicillin resistant E. coli during the 
winter season. The highest E. coli counts were detected in summer. The warmer conditions 
during summer have been found to contribute to persistence of E. coli (Oliver & Page, 2016). 
Along with this, Okains Bay is a popular location for visitors during summer. The higher E. coli 
concentrations may be due to a combination of both factors.  
 
High concentrations of E. coli were consistently detected in the tributary (site T). This highlights 
one pathway of E. coli contamination into the Opara Stream. Through ESR, I was able to obtain 
a sample from one of the sources of the Opara Stream, a spring on Thacker’s Farm. E. coli was 
detected in this source. This indicates contamination of the spring itself, however, as this was 
only a one-off sampling event, the results may not be truly representative. Frequent monitoring is 
needed to determine whether the presence of E. coli is consistent. Across all seasons, E. coli was 
detected at the most upstream site. This site is 5.3 km from the most downstream site. The 
increasing concentrations of E. coli and ampicillin resistant E. coli going downstream during 
some seasons indicates that there may be multiple input sources of E. coli. In future, gathering 
samples from further upstream than site U could provide a better insight as to potentially where 
contamination begins.  
 
The old schoolhouse’s UV irradiation system and filter seemed to fail consistently, leading to 
noncompliance for drinking water. E. coli concentrations were just above the detection limit at 
the schoolhouse in autumn (1 cfu 100 mL-1). At this point the school had moved into a new 
building and had not used that building in months. In autumn, the other sites still had E. coli 
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concentrations well above the detection limit, and during the summer season, E. coli 
concentrations at the old schoolhouse were above the detection limit again, suggesting that the 
autumn observation was an artefact and was likely due to the water being stagnant in the pipes 
for some time. 
 
The results from the toothbrush experiment showed that were no significant differences between 
methods of water exposure, and no significant differences between toothpaste and no toothpaste. 
E. coli could only be detected when enriched in LB agar immediately after exposure to the water. 
These results are not representative of the microbial load that may exist on toothbrush heads. The 
toothbrushes were sterile, which is not the case for regularly used toothbrushes. As observed 
with the embedded toothbrush heads, E. coli could be detected immediately after water exposure. 
Further analysis could determine the abundance of E. coli immediately after exposure to water 
through the sonication, vortex, and filtration steps to gather more quantitative information. 
 
Conclusion 
The results of this study showed that raw water that is influenced by different anthropogenic 
activities can harbour antibiotic resistant populations of E. coli. This was observed by the 
significant differences in Treated and Stream. As many sites were only sampled once, it is not 
possible to generalize that different land uses were the explanation for the differences between 
sites. However, treated drinking water harboured significantly lower E. coli than drinking water 
sourced from untreated streams in all regions, concluding that treatment of raw water in rural 
environments is essential for access to potable water. In the Okains Bay case study, seasons had 
a significant effect on E. coli concentrations across the sites, as well as resistant populations.  
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Chapter 3: Study on the prevalence and diversity of 
multidrug resistant E. coli in rural water sources 
As discussed in Chapter 1 and 2, antibiotic resistance occurs at easily detectable frequencies in 
the New Zealand environment. This chapter focuses on the antibiotic susceptibility profiles of 
the E. coli isolates that were detected in the water quality experiments in Chapter 2 against eight 
antibiotics from seven different classes, as well as extended spectrum β-lactamase (ESBL) 
production, and ampC β-lactamase (AmpC) production. The ability of the E. coli isolates to 
share genetic material conferring antibiotic resistance is also explored. The data explored in this 
chapter contributes to the growing body of evidence that MDR bacteria are present in our 
environment.   
3.1 Antibiotic classifications 
Antibiotics from eight antibiotics from seven different classes were used for this work. All eight 
antibiotics are on the WHO’s Model List of Essential Medicines (World Health Organisation, 
2019b), and are classed as ‘highly’ or ‘critically’ important for human therapeutics (World 
Health Organisation, 2018). The WHO released the ‘2019 AWaRe Classification Antibiotics 
database, where it classifies 180 antibiotics and antibiotic combinations into the following 
groups: ‘Access’, ‘Watch’, and ‘Reserve’ (World Health Organisation, 2019a). A description of 
each group is shown in Table 7. 
 
Table 7 Description of the WHO’s 2019 AWaRE Classification Antibiotics groups. All of the information in this 
table was obtained from WHO, 2019c. 
Group Description 
Access Antibiotics that have activity against a broad range of susceptible pathogens while also 
showing lower resistance potential than antibiotics in other groups.  
Watch Antibiotics that have higher resistance potential and/or have a relatively high risk of 
selection for bacterial resistance. 
Reserve Antibiotics that should be reserved for treatment of confirmed or suspected infections. 
These should be treated as ‘last resort’ options used for specific situations where 




3.2 Introduction to antibiotics used in this thesis 
Antibiotics are often used in both human healthcare and veterinary medicine. This makes it 
important to monitor antibiotic resistance in both clinical and environmental isolates as resistant 
zoonotic pathogens can cause serious problems for treatment of common infections. Figure 8 
shows the antibiotics used in my thesis research and how they are used in New Zealand. Half of 
the eight antibiotics are used in humans, companion animals and livestock, and all four 
antibiotics used on livestock are used on both humans and companion animals.  
 
 
Figure 8 The antibiotics used in this thesis research and the different sectors in which they are used in in New 
Zealand. 
3.2.1 Rifampicin  
Rifampicin is an antimycobacterial antibiotic but is also effective against a large range of 
bacterial pathogens. It remains an important alternative antibiotic for infections caused by 
pathogens such as MRSA (Moellering, 2008). It is classed as a ‘Critically Important 
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Antimicrobial’ and has been placed in the ‘Watch’ group (World Health Organisation, 2018, 
2019b). Rifampicin inhibits RNA polymerase, thereby preventing transcription (Wehrli, 1983). 
Rifampicin resistance is generally caused by mutations in the rifampicin resistance determining 
region (RRDR), a 81bp region in the rpoB gene (Goldstein, 2014). In New Zealand, rifampicin is 
used to treat bacterial infections in humans and animals (Ministry for Primary Industries, 2005; 
Ministry of Health, 2019b; Page, 2017). Rifampicin is excreted through urine and faeces with 
less than 30% excreted unchanged (Wishart et al., 2018). New Zealand has a low incidence of 
clinically relevant rifampicin resistance. In 2004, 1% of Mycobacterium tuberculosis and M. 
bovis isolated from TB positive patients were resistant to rifampicin (Heffernan, 2004), and 
between 2007 and 2016, no significant trends in resistance to rifampicin have been observed 
(Institute of Environmental Science and Research, 2019). In 2010, the first case of extensively 
drug resistant (XDR) TB was identified in New Zealand (Goh et al., 2011). No other reports of 
XDR TB in New Zealand have been identified since.  
 
3.2.2 Trimethoprim  
Trimethoprim is an antifolate antibiotic. It is classed as a ‘Highly Important Antimicrobial’ and 
has been placed in the ‘Access’ group (World Health Organisation, 2018, 2019b). Trimethoprim 
binds to dihydrofolate reductase (DHFR), preventing the reduction of dihydrofolic acid (DHF) to 
tetrahydrofolic acid (THF), inhibiting the synthesis of folic acid and DNA (Brogden et al., 1982). 
In New Zealand, trimethoprim is used to treat bacterial infections in humans, companion 
animals, and livestock (Ministry for Primary Industries, 2005; New Zealand Veterinary 
Association, 2018a). It is commonly used in conjunction with sulphonamides. In 2014, it was 
one of the top ten most heavily consumed antibiotics in human healthcare in New Zealand 
(Williamson et al., 2016). Trimethoprim can be purchased without prescription from registered 
pharmacists (Gauld et al., 2017; Ponen, 2019b). Trimethoprim is excreted unchanged through 
urine, with approximately 50-60% of trimethoprim excreted within 24 hours of oral 
administration (Health Canada Product Monograph, 2014). 
 
Trimethoprim resistance is increasing in New Zealand. Between 2007 and 2015, there was an 
increase in trimethoprim resistance in clinical isolates, though this increase was not associated 
with the change in trimethoprim availability that stemmed from changes in prescription 
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regulation in 2012 (New Zealand Medicines and Medical Devices Safety Authority, 2018). In 
2017, 25.9% of non-ESBL-producing E. coli and 69.8% of ESBL-producing UTI E. coli isolates 
from humans in New Zealand were resistant to trimethoprim (Institute of Environmental Science 
and Research, 2017a). These data support the relationship between trimethoprim resistance and 
ESBL-producing bacteria that have been seen in clinical isolates in other studies (Auer et al., 
2010; Critchley et al., 2019; Rodríguez-Baño et al., 2018). In comparison, trimethoprim resistant 
E. coli isolated from UTIs from companion animals decreased from 6.5% in 2005 to 2.8% in 
2012 (McMeekin et al., 2017). In dairy cows, 0.5-17% of Staphylococcus spp. were resistant to 
trimethoprim/sulfamethoxazole (McDougall et al., 2014).  
 
3.3.3 Gentamicin and kanamycin 
Gentamicin and kanamycin are aminoglycoside antibiotics, and both are classed as ‘Critically 
Important Antimicrobials’. Gentamicin has been placed in the ‘Access’ group and kanamycin 
has been placed in the ‘Watch’ group (World Health Organisation, 2018, 2019b). 
Aminoglycosides inhibit protein synthesis in bacteria, negatively impacting translation of mRNA 
(Davies & Davis, 1968). Aminoglycoside sales for agriculture and horticulture in New Zealand 
have decreased over the last few years. The distribution of aminoglycoside sales in 2017 was 
horticulture (69%), livestock species (pigs, sheep, cattle; 24%) and companion animals, 
including horses (7%) (New Zealand Food Safety, 2019). In New Zealand, gentamicin is used to 
treat bacterial infections in humans and companion animals (CDHB Antimicrobial Stewardship 
Committee, 2020; Ministry for Primary Industries, 2005; Page, 2017). while, kanamycin is used 
as a second line treatment for tuberculosis (Ministry of Health, 2019b). Gentamicin is excreted 
unchanged in urine, with 70% or more unchanged gentamicin recovered in urine within 24 hours 
of administration (Wishart et al., 2018). Similarly, kanamycin is excreted unchanged through 
urine (Kunin, 1966). Gentamicin resistance has been observed in clinical human bacterial 
isolates in New Zealand, and at low frequencies in the environment (Adewale, 2018; Institute of 
Environmental Science and Research, 2017a; Schousboe et al., 2015). In clinical isolates, 
gentamicin resistance is detected more frequently in ESBL-producing Enterobacter spp. than in 
non ESBL-producers (Institute of Environmental Science and Research, 2017a). No data was 




Chloramphenicol is an amphenicol antibiotic and it is classed as a ‘Highly Important 
Antimicrobial’ and has been placed in the ‘Access’ group (World Health Organisation, 2018, 
2019b). Chloramphenicol binds to the 50S ribosomal subunit in bacteria, suppressing peptidyl 
transferase activity and interfering with protein synthesis (Wishart et al., 2018). In New Zealand, 
chloramphenicol is used to treat bacterial infections in humans. Use in animals is not permitted 
(New Zealand Food Safety, 2018). It is the first-choice treatment for bacterial conjunctivitis and 
can be obtained without a prescription from a registered pharmacist (Health Navigator, 2017; 
Ponen, 2019a). Chloramphenicol is predominantly excreted through urine as the inactive 
metabolite chloramphenicol glucuronate, with between 5-15% excreted unchanged through urine 
(Ambrose, 1984). Chloramphenicol resistance is not common in New Zealand, but it has been 
observed before. Clinical isolates of chloramphenicol resistant Streptococcus pneumoniae were 
identified at a rate of 1.2 - 3.4% between 2001 and 2010 (Heffernan, 2011; Ikram, 2010). 
Amongst non-typhoidal Salmonella, chloramphenicol resistance was observed in 2.5% of human 
isolates but not in environmental isolates (Institute of Environmental Science and Research, 
2016). In Shigella spp., chloramphenicol resistance was observed in 28.5% of clinical isolates 
tested between 2015 and 2016 (Institute of Environmental Science and Research, 2017b).  
 
3.3.5 Ciprofloxacin  
Ciprofloxacin is a fluoroquinolone antibiotic. It is classed as a ‘Critically Important 
Antimicrobial’ and has been placed in the ‘Watch’ group (World Health Organisation, 2018, 
2019b). Ciprofloxacin inhibits DNA replication by targeting the essential type II topoisomerase 
enzymes DNA gyrase and topoisomerase IV and can also inhibit DNA transcription and 
translation at some concentrations (Jacoby, 2005). The emergence of resistant populations is 
predicted to be a result of the extensive use of ciprofloxacin, as well as other fluoroquinolones 
(Hooper, 2001). This is due, in part, to chromosomal mutations in the target enzymes DNA 
gyrase and topoisomerase IV, as well as mutations which alter the expression of diffusion 
channels and efflux systems (Hooper & Jacoby, 2016). In New Zealand, ciprofloxacin is used to 
treat bacterial infections in humans, animals, and in livestock (Ministry for Primary Industries, 
2005; New Zealand Medicines and Medical Devices Safety Authority, 2012). In 2014, it was one 
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of the top ten most heavily consumed antibiotics in human healthcare in New Zealand 
(Williamson, 2016). Ciprofloxacin is excreted unchanged through urine and faeces, with higher 
concentrations detected in faeces than in urine (LeBel, 1988). Trends of ciprofloxacin resistance 
varies across clinical isolates in New Zealand, however, overall, it is slowly increasing 
(Heffernan et al., 2018; Wellington SCL, 2020). Ciprofloxacin resistance is also strongly 
associated with ESBL-production. This has been observed globally, as well as in New Zealand 
(Institute of Environmental Science and Research, 2017a). 
 
3.3.6 Ampicillin  
Ampicillin belongs to the antibiotic class penicillin. It is classed as a ‘Critically Important 
Antimicrobial’ and has been placed in the ‘Access’ group (World Health Organisation, 2018, 
2019b). Penicillins were amongst the most purchased classes of antibiotic in New Zealand 
between 2011 and 2017, and they had the highest use in companion animals and in cattle (New 
Zealand Food Safety, 2020). Penicillin prevents cell wall synthesis by binding to penicillin-
binding proteins (PBPs), inhibiting cell wall peptidoglycan synthesis (Yocum et al., 1980). In 
New Zealand, ampicillin is used to treat bacterial infections in humans, companion animals, and 
in livestock (Baoumgren, 2019; Bryan & Hea, 2017; Ministry for Primary Industries, 2005; The 
New Zealand Veterinary Association, 2018). Ampicillin is excreted unchanged through urine, 
bile, and faeces (Wishart et al., 2018). Ampicillin resistance has been observed in livestock 
(Nulsen et al., 2008), and in the New Zealand environment (Adewale, 2018; Schousboe et al., 
2015; Van Hamelsveld et al., 2019). 
 
3.3.7 Tetracycline  
Tetracycline belongs to the tetracycline family of antibiotics. It is classed as a ‘Highly Important 
Antimicrobial’ and has been placed in the ‘Access’ group (World Health Organisation, 2018, 
2019b).  Tetracycline inhibits protein synthesis by binding to the 30S ribosomal subunit (Chopra 
& Roberts, 2001). In New Zealand, tetracycline is used to treat a wide range of infections in 
humans, companion animals and livestock (Best Practice Advocacy Centre New Zealand, 2012; 
New Zealand Food Safety, 2020; New Zealand Veterinary Association, 2018b). Tetracycline is 
excreted unchanged in high concentrations through urine and faeces (Wishart et al., 2018). 
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Tetracycline resistance has been observed in New Zealand in surface waters (Adewale, 2018; 
Van Hamelsveld et al., 2019), in livestock (French et al., 2019; Nulsen et al., 2008), and in 
human clinical isolates (Institute of Environmental Science and Research, 2017a). 
 
3.3 Extended Spectrum β-Lactamases (ESBL) and AmpC β-Lactamases 
(AmpC) 
 
Extended spectrum β-lactamase-producing (ESBL) bacteria and AmpC β-lactamase-producing 
(AmpC) bacteria are important threats to how antibiotics are used to treat infections, and are 
often associated with poor treatment outcomes, higher morbidity, and mortality, and increase 
health care costs (Brook, 2009; Drinkovic et al., 2015; Jacoby, 2009). β-lactamases are 
hydrolytic enzymes that confer resistance to β-lactam antibiotics such as penicillins and 
cephalosporins by cleaving the beta-lactam ring (Dhillon & Clark, 2012). They can be 
chromosomal or plasmid genes and can confer resistance to a wide array of commonly used non 
β-lactam antibiotics (Brook, 2009; Toombs-Ruane et al., 2017). ESBL-producers are inhibited by 
β-lactamase inhibitor (BLI) combinations while AmpC βL-producers are resistant to BLI 
combinations but are usually sensitive to carbapenems (Grover et al., 2013; Jacoby & Han, 
1996). 
 
ESBL and AmpC βL enzymes are primarily produced by members of the Enterobacteriaceae 
family and display stronger resistance phenotypes than non-producers (Grover et al., 2013; 
Jacoby, 2009). This has been seen in clinical isolates in New Zealand, as discussed above. 
ESBL-producing E. coli can pose a significantly higher risk of complications to humans than 
non-ESBL-producing E. coli (Briñas et al., 2005; Melzer & Petersen, 2007). Ampicillin, 
ciprofloxacin, gentamicin, and trimethoprim resistance have been previously associated with 
ESBL-producing bacteria (Grover et al., 2013; Liu et al., 2011; Paterson & Bonomo, 2005). 
Ampicillin is a β-lactam antibiotic that is susceptible to β-lactamase hydrolysis, however, it is 
suggested that genes conferring resistance to ciprofloxacin and gentamicin may share a 




In New Zealand, ESBL- and AmpC βL-producing bacteria have been found in hospitals, in the 
community and in the environment. They have been identified in humans, companion animals 
and in livestock. Between 2005 and 2014, ESR conducted one-month long surveys of ESBL-
producing Enterobacteriaceae from hospital and community patients. Their latest report found 
that between 2007 and 2016, ESBL-producing E. coli populations increased from 52% to 74.1% 
(Heffernan, 2018). Further, the ESBL-producing E. coli populations were predominantly found 
in community patients (68.1%), with more than half of the populations resistant to ciprofloxacin 
(62.6%) and trimethoprim (66.7%). In the Auckland community, the prevalence of AmpC-
producing E. coli has increased in recent years. In 2011, genetically unrelated AmpC-producing 
E. coli were identified in human urine samples, and they were significantly more resistant to 
other antibiotics than their non-AmpC βL-producing counterparts (Drinkovic et al., 2015). 
ESBL- and AmpC-producing bacteria have been found in clinical isolates from companion 
animals in New Zealand as well. Karkaba et al. (2017) identified ESBL- and AmpC-producing 
Enterobacteriaceae that were often MDR in companion animals and found that these isolates 
were resistant to more antibiotics than non ESBL- and non AmpC βL-producing isolates. In 
livestock, the prevalence of ESBL- and AmpC βL-producing E. coli is low, however, they are 
still detected (Burgess et al., 2021). In New Zealand waterways, Adewale (2018) and Van 
Hamelsveld et al. (2019) identified ESBL-producing E. coli in the Ōtākaro/Avon river, an urban 
river which runs through Christchurch, and Silverstream, a rural stream that drains an area used 
for agriculture. Their results demonstrate that ESBL-producing E. coli are present in both urban 
and agricultural environments.  
 
3.4 Spreading of antibiotic resistant genes 
Horizontal gene transfer has been recognised as a contributor to the declining efficiency of 
antibiotics (D'Costa et al., 2006). Conjugation is one of the principle routes that aids the 
dissemination of antibiotic resistance genes, as conjugative plasmids often harbour multiple 
antibiotic resistance genes (Wozniak & Waldor, 2010), and in Enterobacteriaceae, conjugation 
is the most common mechanism for spreading antibiotic resistance genes (Bethke et al., 2020). 
The spread of antibiotic resistance in hospitals and communities have largely been the focus of 
antibiotic stewardship, however the natural environment is also a reservoir of resistant 
determinants and resistant bacteria (Abe et al., 2020). A proportion of antibiotics that are 
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consumed in humans, animals and livestock can often be excreted unchanged into the 
environment. These residues can end up in our waterways, contributing to the antibiotic 
‘resistome’ (Figure 1). Antibiotic resistance and resistant determinants can be detected in 
environments without selective pressure, suggesting that they persist in those environments 
through bacterial populations (Abe et al., 2020; Gullberg et al., 2011). Aquatic environments 
represent large reservoirs of antibiotic resistant genes and include a mixture of clinical, 
terrestrial, and human commensal bacteria (Abe et al., 2020). Some commensal bacteria are 
opportunistic pathogens, which becomes an issue when they harbour antibiotic resistant genes 
that they may have acquired from the environment (D'Costa et al., 2006). The human 
gastrointestinal tract is a prime location for horizontal gene transfer, which includes transfer of 
antibiotic resistance genes to other pathogens (Broaders et al., 2013). When relating this back to 
our tourist visiting rural New Zealand, being exposed to MDR bacteria from surface waters has 
more serious implications as the environmental bacteria and gut bacteria may interact, further 
disseminating resistant determinants or alternatively, they may pick up a MDR pathogen leading 
to difficulties when it comes to treatment.  
 
3.5 Main hypothesis 
Hypothesis 1: Tourists will be exposed to more MDR E. coli than recognised because of their 
concentrated experience with water supplies that are rarely or never monitored. This was tested 
by measuring the concentration of both E. coli and MDR E. coli in these water sources.  
Hypothesis 2: MDR E. coli isolated from the environment will be able to share resistant 
determinants with susceptible bacteria through horizontal gene transfer. This hypothesis will be 
supported if resistance is observed in a susceptible lab strain after conjugation experiments. This 
hypothesis would not be supported if sharing of resistance genes is not observed.  
Hypothesis 1 will be tested by comparing the antibiotic susceptibility profiles of E. coli isolates 
from the three drinking water sources: Treated, Stream and Other. Hypothesis 2 will be tested by 




3.6 Antibiotic Susceptibility Assay 
E. coli isolates from the water quality experiments in Chapter 2 and a standard laboratory strain 
and susceptible environmental strain (Table 8) were used for the antibiotic susceptibility assay. 
Antibiotics were purchased from Becton Dickinson, Sigma, Oxoid or Duchefa, and liquid stock 
solutions were prepared according to the manufacturers’ instructions. Random representative 
populations were selected from TBX only, TBX supplemented with ampicillin, TBX 
supplemented with ciprofloxacin, and TBX supplemented with chloramphenicol plates. The 
antibiotic susceptibility assay is based on Adewale (2018) and Van Hamelsveld et al. (2019) with 
minor modifications. Liquid LB (10 ml) was inoculated with the isolates and grown with 
aeration to saturation in a 37℃-shaking incubator. 4 μL aliquots were transferred to LB plates 
supplemented with antibiotics. The concentrations used and the clinical breakpoints as per the 
Clinical and Laboratory Standards Institute (CLSI) guidelines are shown in Table 9 (Clinical and 
Laboratory Standards Institute, 2020). Isolates were tested up to their minimum inhibitory 
concentrations (MIC).  
 
Table 8 Bacterial strains used as controls in this study. 
Strain Species Genotype 
CMB41 E. coli Environmental strain. Susceptible to all antibiotics in used in antibiotic 
susceptibility assay 





Table 9 Antibiotics used and their concentration range to determine resistance.  
Antibiotic Concentration Range Tested μg mL−1 
 Susceptible Intermediate Resistant 
Ampicillin ≤ 8 16 32 ≤ 
Kanamycin ≤16  32 64 ≤ 
Gentamicin ≤ 4  8 16 ≤ 
Tetracycline ≤ 4 8 16 ≤ 
Chloramphenicol ≤ 8  16 32 ≤ 
Ciprofloxacin ≤ 0.25 0.5 1 ≤ 
Rifampicin - - 100 
Trimethoprim ≤ 8  - 16 ≤ 
 
 
3.7 Extended Spectrum β-Lactamase (ESBL) and AmpC β-Lactamase 
(AmpC β-L) Screening 
 
104 E. coli isolates that were resistant to ampicillin (≥16 µg/mL) and/or ciprofloxacin (≥1 
µg/mL) were screened for ESBL production. Strains were transferred from frozen stocks by 
streaking onto plates of LB agar and incubated for 16 h in a 37°C incubator. The following day, 
a single colony was chosen and grown in 10 mL liquid LB for 4 hours at 37°C or until OD600 
reached 0.5.  200 µL of culture was spread onto LB agar in a petrie dish and left to dry for five 
minutes. After this drying period, the following antibiotic discs were placed as shown in Figure 
9: 1) cefotaxime 30 μg, 2) ceftazidime 30 μg, 3) cefotaxime and clavulanic acid 30/10 μg, and 4) 
ceftazidime and clavulanic acid 30/10 μg. The antibiotic susceptibility discs used were BD 
BBLTM Sensi-DiscsTM purchased from Becton Dickinson. Resistance to cefotaxime and 
ceftazidime were determined as per the CLSI guidelines, and a positive result for ESBL 
production was indicated by a growth difference of ≥5 mm between cefotaxime and) cefotaxime 
and clavulanic acid, and ceftazidime and ceftazidime and clavulanic acid (Clinical and 







Figure 9 Placement of antibiotic discs in ESBL and AmpC screening assay. 
 
3.8 Conjugation experiments 
Antibiotic resistance gene transmission by conjugation was observed qualitatively and 
quantitatively. Isolates were screened for donor activity using a qualitative assay. Those that had 
a detectable donor activity were chosen for the quantitative assay. 
 
3.8.1 Qualitative Conjugative Experiments  
A procedure based on Van Hamelsveld et al. (2019) and Heinemann and Ankenbauer (1993) was 
used with modifications. Donor and recipient strains were streaked onto LB agar plates from 
frozen stocks and incubated 18 h at 37°C. For each donor, three different well-separated colonies 
were selected for replicates. The following day, a single colony was chosen, and the donor and 
recipient cultures were grown in 10 mL liquid LB until OD600 = 1 was reached. 10 µL of donor 
and recipient cultures were mixed together as a single 20 µL on LB agar, allowed to dry. Plates 
were incubated for 3 h at 37°C before replica plating onto LB agar containing rifampicin (100 μg 
mL−1) and the donor antibiotic marker, and onto LB agar containing rifampicin (100 μg mL−1) 
only. Plates were incubated for 16 h at 37°C. Putative transconjugants were purified and 
confirmed by streaking onto fresh antibiotic containing LB agar and incubated for another 16 h 
at 37°C. Antibiotic concentrations were determined from the results of the antibiotic 
susceptibility assay.  
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Prior to beginning the quantitative conjugation experiments, a PhD student in my lab group and I 
performed a series of experiments to observe which parameters would be optimal for conjugation 
to occur between the environmental and lab E. coli strains. This preliminary analysis stemmed 
from issues with low conjugation efficiency during quantitative conjugation experiments. 
Different growth parameters were explored; 1) temperature, 30°C vs 37°C, 2) multiple 
exponential growth phases to dilute conjugation repressors, and 3) mating times, 3 h versus 
overnight. We concluded that growth to two exponential phases (OD600 = 0.5) and overnight 
mating was sufficient to increase conjugation efficiency.  
 
3.8.2 Quantitative Conjugative Experiments  
Transmission rates were quantified for a sub-set of the environmental MDR E. coli isolates. E. 
coli JB570 was selected as the recipient strain (Table 8). The initial steps of the procedure for 
this experiment were the same as the qualitative conjugation experiments. The mating mix was 
in a liquid culture instead of solid agar, and donor and recipient cultures were mixed in fresh 
liquid LB at a ratio of 1:10, to ensure recipient concentration was not a limiting factor. This 
mating mix was incubated for 18 h in a non-shaking 30°C incubator.  A dilution series was used 
to quantify the rate of transmission. The donor replicates were transferred to LB agar containing 
the donor antibiotic marker, and the transconjugants were transferred to LB agar containing 
rifampicin (100 μg mL−1) and the donor antibiotic marker. Plates were incubated for 16 h at 
37°C, and the following day, the transmission rate was determined by the number of 
transconjugants divided by the number of limiting parents (donor).  
 
3.9 Statistical analysis 
Across the three regions, I was interested MDR E. coli was dependent on the water source, and 
whether there were differences across the regions. The same sites that were used in the water 
quality analysis in Chapter 2 were used for this analysis. To compare the MDR isolates, the total 
counts of MDR per site were used instead of the concentration relative to total E. coli. This was 
because total E. coli was not found to be predictive of resistant populations. A GLMM with a 
Poisson log link was selected for analysis of MDR isolates because the MDR counts followed a 
Poisson distribution, the variance was not normally distributed, and the water sources categories 
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were unbalanced. Over dispersion was accounted for by assigning each observation a unique 
value and including this as a random effect in the analysis. 
 
In Okains Bay, I was interested in whether there were seasonal effects on MDR E. coli, and 
whether there were differences across the sites. For both analyses, a GLMM with a Poisson log 
link was selected for analysis of MDR isolates because the MDR counts followed a Poisson 
distribution, the variance was not normally distributed, and the water sources categories were 
unbalanced. Over dispersion was accounted for by assigning each observation a unique value and 





3.10 MDR assay 
Treated had significantly fewer MDR E. coli than Stream (p <0.0454). Other in Banks Peninsula 
had significantly more MDR E. coli than Treated in Canterbury (p = 0.039). Within Canterbury, 
Stream had significantly more MDR E. coli than Treated (p = 0.0274). The detailed statistical 
output from this analysis can be found in Appendix A12. 
 
3.11 Antibiotic Susceptibility Assay 
The following results include E. coli isolates from sites that were not included in the statistical 
analyses. See Appendix B for a list of MDR E. coli isolates from this analysis. A total of 535 E. 
coli isolates were tested against eight antibiotics in the antibiotic susceptibility assay. Among the 
tested isolates, 55% were directly isolated on TBX with no antibiotics supplemented. The others 
were isolated on either ampicillin, chloramphenicol, or ciprofloxacin. E. coli strains JB570 and 
CMB41 were used as controls (Table 8).  
 
Of the 535 isolates, 15% were MDR. Among the MDR isolates, 1% were isolated from Treated, 
46% were isolated from Other, and 53% were isolated from Stream.  The highest numbers of 
multidrug resistance arose from TBX without supplemented antibiotics, closely followed by E. 
coli that were isolated on TBX supplemented with ampicillin (Table 10). Of the isolates tested, 
the most common resistance observed was ampicillin resistance and gentamicin resistance, 
followed by ciprofloxacin resistance (Table 10).  Ampicillin and gentamicin resistance were 









Table 10 The number of isolates resistant to antibiotics used in the antibiotic susceptibility assay and the media 
which they were isolated on.  
Isolated on Amp Chl Rif Tet Kan Tmp Gen Cip 
Total 
MDR 
TBX 79 8 15 17 3 3 93 85 36 
Amp 85 1 11 6 16 2 74 19 30 
Chl 4 4 1 2 5 1 4 2 3 
Cip 3 3 2 1 0 7 0 63 12 
Total 171 13 29 26 24 13 171 169  
 
Table 11 shows the distribution of resistances observed across the water sources and across the 
three regions. Although MDR was rare in Treated, its frequency amongst the E. coli found there 
was high. E. coli isolated from Treated had the highest proportion of resistant isolates (n =4, 
MDR = 25%), followed by Other (n = 196, MDR = 19%) and Stream (n = 330, MDR = 13%). In 
Banks Peninsula, the most common resistance observed was ciprofloxacin resistance, followed 
by gentamicin resistance. In Canterbury, the most common resistance observed was ampicillin 
resistance, followed by gentamicin and ciprofloxacin resistance. In Marlborough, the most 
common resistance observed was ampicillin resistance, followed by gentamicin resistance.  
 






Amp Chl Rif Tet Kan Tmp Gen Cip MDR 
Other 196 52% 5% 2% 6% 6% 9% 40% 34% 19% 
Stream 330 20% 1% 6% 4% 4% 2% 26% 31% 13% 
Treated 4 50% 0% 50% 0% 0% 25% 0% 25% 25% 
Banks 
Peninsula 
370 24% 1% 4% 2% 5% 3% 32% 36% 14% 
Canterbury 48 83% 0% 17% 58% 0% 0% 58% 58% 15% 




3.12 Extended Spectrum β-Lactamase Screening  
A total of 104 E. coli strains that were resistant to ampicillin or ciprofloxacin were screened 
against cefotaxime, ceftazidime, and in combination with clavulanic acid. 33 (17%) isolates were 
resistant to cefotaxime, and 14 (14%) isolates were resistant to ceftazidime. Of the isolates 
resistant to cefotaxime, 5 (15%) were found to have a zone of inhibition greater than 5 mm 
around the cefotaxime/clavulanic acid antibiotic disc, which was a phenotypic confirmation of 
ESBL-producing E. coli. The remaining 32 (31%) isolates were phenotypically confirmed to be 
AmpC-producers. Of the ESBL- and AmpC-producers, 11 (30%) were resistant to both 
ampicillin and ciprofloxacin. I tested the possibility that ampicillin and ciprofloxacin resistance 
could be predictive of ESBL- and AmpC-production. Ampicillin resistance was not predictive of 
ESBL- or AmpC-production. Ciprofloxacin resistance was not predictive of EBSL-production, 
but it was predictive for AmpC-production (p <0.027). ESBL and AmpC production was not 
associated with MDR in the tested isolates. A list of isolates that displayed a ESBL- or AmpC-
producing phenotype can be found in Appendix C.  
 
3.13 Conjugation 
3.13.1 Qualitative conjugation experiments 
Conjugative activity was observed in 64% of the 123 E. coli strains tested. Ampicillin and 
gentamicin resistance were most commonly found to be linked on a conjugative genetic element, 
followed by ampicillin and ciprofloxacin. Of the donors, 52%, 32%, 14% and 2% were resistant 
to one, two, three or four antibiotics, respectively. Only one isolate transferred all resistant 
markers (four resistant markers) to the recipient (1%). 14% transferred three resistant markers, 
and 33% transferred two resistant markers. Table 12 shows the isolates which showed a donor 







Table 12 Isolates showing a donor phenotype and the resistances observed in transconjugants after the conjugation 








3.13.2 Quantitative conjugation experiments 
A total of 22 strains were tested in a quantitative conjugation assay. Donors sourced from 
drinking water taps were selected from amongst the donors tested in the qualitative conjugation 
assay. Conjugation frequencies ranged from 1 x 10-1 to 2.95 x 10-7 cfu mL-1 (Table 13). The 
highest frequency of conjugation observed was in E. coli strain 2OB22 which had an efficiency 
of plating (EoP) of 1 x 10-1 for gentamicin resistance. Overall gentamicin resistance was 
transferred at a higher frequency than ampicillin, chloramphenicol, and ciprofloxacin resistance. 
Cross resistance was observed in three strains. 
 
Table 13 Results from the qualitative conjugation experiments. – indicates no observation of cross resistance. 
Isolated from E. coli strain Resistant to 
Transconjugant per 







3OB1A10 Ciprofloxacin 1 x 10-5 Gentamicin 
Gentamicin 1 x 10-5 Ciprofloxacin 
3OB1A1001 Gentamicin 3 x 10-4 - 
3OB2A12 Gentamicin 2 x 10-4 - 
OB21 Gentamicin 9 x 10-2 - 
Ampicillin 1 x 10-3 - 




S3CHL Ampicillin 5 x 10-4 Gentamicin 
Gentamicin 5 x 10-4 Ampicillin 
S1CHL Gentamicin 2 x 10-4 - 
AS1A Gentamicin 8 x 10-3 - 
AS2A Ampicillin 3 x 10-2 - 




K3C3 Ampicillin 5 x 10-5 Ciprofloxacin 






Table 13 continued. 
Sharplin Falls 
Carpark 
SF12 Ampicillin 6 x 10-6 - 
Gentamicin 4 x 10-5 - 
Ciprofloxacin 3 x 10-5 - 
SF13 Gentamicin 1 x 10-3 - 
 Ciprofloxacin 6 x 10-4 - 
SF15 Gentamicin 6 x 10-5 - 





1WHA13 Ampicillin 3 x 10-7 - 
Gentamicin 2 x 10-6 - 
Chloramphenicol 2 x 10-7 - 
1WHA16 Ampicillin 3 x 10-5 - 
Gentamicin 2 x 10-4 - 
Chloramphenicol 3 x 10-5 - 
1WHA22 Gentamicin 2 x 10-4 - 
1WHA24 Gentamicin 5 x 10-4 - 
Ciprofloxacin 4 x 10-4 - 
1WHA25 Gentamicin 5 x 10-5 - 
1WHA29 Gentamicin 6 x 10-5 - 




W3A6 Ciprofloxacin 7 x 10-4 - 
 
 
3.14 Case study: Okains Bay  
In Okains Bay, I wanted to test whether seasons had a significant effect on MDR E. coli 
populations. I also wanted to test whether MDR E. coli varied by sampling site. The sites 
included in this analysis were tributary (T), upstream (U), bridge (B), school (S), campground 
kitchen (K), and estuary (E), which are sites along the Opara Stream, and residential home (RH) 
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which sources its drinking water from a tributary that feeds into the Opara Stream near the 
estuary. 
 
Seasons had no effect on MDR E. coli observations along the Opara stream. Table 14 shows the 
antibiotic resistance profiles of the E. coli isolates included in the seasonal analysis. The detailed 
statistical output for this analysis can be found in Appendix A13. The counts of MDR E. coli did 
not significantly differ between the sites along the Opara Stream and were consistent over the 
four seasons, however, all these sites had significantly fewer MDR E. coli than the RH site. 
Across the seven sites, gentamicin resistance was the most observed resistance, followed by 
ampicillin resistance and ciprofloxacin resistance. 
 




tested Amp Chl Rif Tet Kan Tmp Gen Cip MDR 
Winter 117 54% 0% 0% 0% 8% 0% 64% 0% 12% 
Spring 93 64% 0% 5% 0% 45% 0% 23% 9% 12% 
Autumn 93 1% 0% 2% 0% 0% 5% 0% 75% 8% 





Overall, the results from the antibiotic susceptibility assay indicate that there was significantly 
fewer MDR E. coli in Treated than in Stream. MDR E. coli numbers were not significant 
differently between the three regions. A large proportion of the isolates that were tested were 
able to transfer resistance genes to other susceptible bacteria, and ESBL- and AmpC-producing 
E. coli were detected in all three water sources.  
 
Selecting for resistant populations using low concentrations of antibiotics was sufficient to 
isolate MDR E. coli, but population densities were high enough that enrichment using low 
concentrations of antibiotics was not necessary. MDR E. coli easily could be identified amongst 
E. coli on TBX without supplemented antibiotics. The largest number of MDR E coli was in fact 
detected from these unenriched cultures.  
 
MDR E. coli were not significantly different across the three regions. The results from this 
chapter further support the fact that total E. coli concentrations are not predictive of resistant 
populations in the environment. This is seen with the E. coli from Treated. The numbers of E coli 
from Treated was small, but they had a higher proportion of MDR. This also reinforces the 
observation that the E. coli concentration per se does not correlate with MDR. 
 
In Banks Peninsula, ciprofloxacin resistance was the most observed resistance in the isolates, 
while ampicillin resistance was the most observed resistance in the other two regions. 
Ciprofloxacin resistance in the Banks Peninsula is skewed by the sampling event after the 
COVID-19 lockdown in New Zealand in 2020, gentamicin resistance was the most predominant 
in Bank peninsula. MDR isolates were observed across the three regions in all water sources. 
One isolate from the Banks Peninsula region was resistant to all eight antibiotics tested. The 
Banks Peninsula region was overly represented in my dataset as I had the Okains Bay case study 
over four seasons. Nevertheless, when controlling for those sampling events, the Banks 




Cross-resistance between ampicillin and gentamicin and ampicillin and ciprofloxacin was often 
observed. These cross-resistances were also frequently observed together in the conjugation 
experiments where ampicillin and gentamicin resistance and ampicillin and ciprofloxacin 
resistance were the most observed resistances shared together with susceptible bacteria. These 
results suggests that the genes conferring resistance to ampicillin and gentamicin, and ampicillin 
and ciprofloxacin resistance may be linked on the same plasmid.  
 
Ampicillin, gentamicin and ciprofloxacin resistance were the most common resistances detected 
in the E. coli isolates. Ampicillin and ciprofloxacin are both used to treat infections in humans, 
companion animals, and in livestock and gentamicin is used to treat infections in humans and 
companion animals. In human clinical Enterobacter spp. isolates, ampicillin, fluoroquinolone 
and gentamicin resistance were detected at the highest frequencies (Institute of Environmental 
Science and Research, 2017a). In the environment, ampicillin and ciprofloxacin resistance are 
often detected, however, gentamicin resistance is not detected at the same frequencies (Adewale, 
2018; Schousboe et al., 2015). No information could be found regarding the use of gentamicin in 
livestock in New Zealand. The detection of gentamicin resistance at a similar a similar frequency 
to ampicillin and ciprofloxacin resistance could suggest significant contamination of surface 
waters from human or companion animal sources. Alternatively, aminoglycosides may have use 
in other sectors that were not explored in this thesis, such as horticulture, and may be entering 
into the environment through that sector.  
 
Tetracycline and rifampicin resistance were detected at the highest frequency in Canterbury. 
Tetracycline is used to treat infections in humans, companion animals and livestock, but 
rifampicin is predominantly used to treat infections only in humans. Tetracycline resistance in 
human clinical isolates is not as common as it is in livestock. Tetracycline resistance has 
previously been detected in high frequencies in pig farms in New Zealand (Nulsen et al., 2008). 
The pork industry is small in New Zealand. Canterbury is the largest pork producer, producing 
approximately 60% of all pork products in New Zealand (Statistics New Zealand, 2020a). The 
pork and poultry sector consume almost half of the antibiotics purchased for use in animals and 
horticulture annually, with tetracycline being one of the antibiotics used in these sectors (New 
Zealand Food Safety, 2020). The higher rates of tetracycline resistance observed in the 
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Canterbury region could be associated with the presence of pork farms. Other studies have found 
rifampicin resistance at high frequencies in the environment (Ibekwe et al., 2011). Rifampicin 
resistance is due to a single point mutation in the rpoB gene. Resistance can occur at a higher 
frequency than the other antibiotics explored in this thesis, however, the occurrence of the point 
mutations still requires the presence of rifampicin. This suggests that there may be rifampicin 
residues in the environment.  
 
Chloramphenicol and kanamycin resistance were some of the lowest frequency resistances 
observed. Chloramphenicol and kanamycin resistance are not common in New Zealand. These 
antibiotics are predominantly used in human medicine, with chloramphenicol not being 
permitted for use in food producing animals in New Zealand (New Zealand Food Safety, 2018). 
Adewale (2018) detected chloramphenicol resistance at a higher frequency in the urban 
Ōtākaro/Avon river, and detected kanamycin resistance in the urban Ōtākaro/Avon River but not 
in the rural Silverstream. The lower detection of chloramphenicol and kanamycin resistance in 
rural surface waters could be due to both antibiotics being reserved for human use. Trimethoprim 
resistance was rare and only detected in Banks Peninsula. In New Zealand, trimethoprim is 
widely used in humans, companion animals, and in livestock. Trimethoprim resistance in clinical 
human isolates has been increasing (New Zealand Medicines and Medical Devices Safety 
Authority, 2018), and resistance in rural environments have been previously detected at low 
frequencies (Adewale, 2018; Van Hamelsveld et al., 2019). Trimethoprim resistance and ESBL-
producing bacteria have been linked in clinical human isolates (Auer et al., 2010; Critchley et al., 
2019; Institute of Environmental Science and Research, 2017a; Rodríguez-Baño et al., 2018), 
however, no association between trimethoprim resistance and ESBL-production was found in my 
isolates.  
 
ESBL-producing E. coli were detected at a lower frequency than AmpC-producing E. coli. 
Ampicillin and ciprofloxacin resistance were not predictive of ESBL production, but 
ciprofloxacin was predictive of AmpC production. In the tested isolates, ESBL and AmpC 
production was not correlated with MDR. This result contrasts what is seen in clinical isolates 





Season had no impact on MDR E. coli counts in Okains Bay. The residential home had 
significantly more MDR E. coli than the sites along the Opara Stream, and MDR E. coli were 
detected in one of the sources of the Opara Stream. This suggests that MDR E. coli are 
contaminating the Opara Stream from the source, however, as this was a one-off sampling event, 
repeat samples would be needed for conformation. There were no significant differences in MDR 
E. coli numbers across the sites along the Opara Stream. This could mean that there are 
consistently MDR E. coli contaminating the stream from the most upstream site that I sampled.  
 
Different resistance patterns were observed between the four seasons. As Banks Peninsula is a 
place with concentrated agricultural uses including livestock farming in catchment areas, the 
differences in the resistance patterns could be associated with different phases in the farming 
cycle. It could also be due to the changes in tourism as an effect of COVID-19. Gentamicin 
resistance was the most commonly observed resistance in Okains Bay, followed by ampicillin 
and ciprofloxacin resistance. As discussed above, this could indicate contamination from humans 
or companion animals.  
 
3.15 Conclusion 
The results from this chapter show that the hypothetical tourist travelling around New Zealand is 
exposed to MDR bacteria that are able to share their resistance genes through their interaction 
with surface waters. This supports both my hypotheses for this chapter. The results obtained 
from the frequency of MDR E. coli from the three water sources across the three regions indicate 
that anthropogenic influence on surface waters may contribute to MDR in the environment. 
Further, preliminary analysis identified that MDR E. coli can be detected in the surface water 
sources. Seasons had no effect on the frequency of MDR E. coli. Further studies will be needed 






Chapter 4: Investigating the underlying genetic 
determinants of resistance and conjugation 
The rising frequency of antibiotic resistance in human-associated pathogens is a threat to human 
health and to the productivity of the plants and animals we cultivate for food, fuel and material. 
To address this threat, we must understand how resistant determinants are evolving. Antibiotic 
resistance is the outcome of pre-existing antibiotic resistance genes amplified through selection 
of phenotypes made fit by our own use of antibiotics and other chemical agents (Rupp & Fey, 
2003), as discussed in Chapter 1. Bacterial resistance can be intrinsic, adaptive or acquired. 
Antibiotic resistance genes can be acquired through horizontal gene transfer or through 
mutations. The acquired resistances may or may not be specific to particular antibiotics. In this 
chapter, the putative biochemical mechanisms of resistance are diagnosed using in silico 
methods.  
4.1 Multi drug resistance efflux transporters and porins 
Native efflux pumps in the bacterial membrane have broad substrate specificity and can confer 
low- and high-level resistance to an array of antibiotics by decreasing drug accumulation within 
bacteria (Hooper, 2001; Huguet et al., 2013). Mutations in the genes which encode for these 
membrane efflux systems can actively increase the efflux of antibiotics out of the cell by either 
deregulating their expression (Alcalde-Rico et al., 2016) or altering their substrate range. 
Mutations in porins can reduce the initial uptake by reducing channels size (Huguet et al., 2013).  
 
Efflux pumps are grouped into five structural families; the resistance-nodulation-division (RND), 
small multidrug resistance (SMR), multi antimicrobial extrusion (MATE), major facilitator 
superfamily (MFS), and the ATP-binding cassette (ABC) superfamilies (Alcalde-Rico et al., 
2016). There are many efflux systems in E. coli, some of which contribute to multidrug 
resistance, but the main multidrug drug resistance efflux system in E. coli is the AcrAB-TolC 
efflux system of the RND structural family (Bergmiller et al., 2017; Li et al., 2015; Wen et al., 
2018). Mutations in AcrAB-TolC regulatory enzymes such as AcrR and MarR have been shown 
to increase multidrug resistance (Sadeghi, 2019; Wang et al., 2001). Overexpression of acrA and 
acrB is strongly associated with fluoroquinolone and multidrug resistance (Swick et al., 2011). 
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Other efflux systems such as MdfA of the MFS structural family are clinically relevant as they 
can confer resistance to structurally unrelated antibiotics (Edgar & Bibi, 1997).  
 
4.2 Point mutations and resistance 
Mutations that give rise to a resistant phenotype are due to a complex mix of factors that 
influence the rate and type of mutation that can occur under antibiotic selective pressure 
(Martinez & Baquero, 2000). Point mutations in the enzymes that are the targets of antibiotics 
can lead to a resistant phenotype. For instance, resistance to rifampicin is primarily caused by 
mutations in the rifampicin resistance determining region (RRDR), an 81bp region in the rpoB 
gene (Goldstein, 2014). These mutations decrease rifampicin’s affinity for the binding site of the 
RNA polymerase. Subtherapeutic doses of rifampicin can select for resistance. This is also seen 
in ciprofloxacin resistance, where the most commonly associated ciprofloxacin resistance 
mechanism is through specific mutations in the quinolone resistance-determining region (QRDR) 
where gyrA, gyrB, parC and parE are present (Aldred et al., 2014). These mutations confer 
resistance by reducing ciprofloxacin’s binding affinity to the enzyme-DNA complex (Hooper & 
Jacoby, 2015; Jacoby, 2005). 
 
As discussed in Chapter 3, ESBL- and AmpC-producing bacteria are important threats to how 
antibiotics are used to treat infections. ESBL enzymes are derived from TEM-1 and -2 through 
point mutations that alter the configuration of the active site (Paterson & Bonomo, 2005). 
AmpC-mediated resistance is predominantly through overexpression of the chromosomal ampC. 
Overexpression of AmpC occurs from mutations in the promoter and attenuator region (Corvec 
et al., 2002; Tracz et al., 2005). Point mutations in the bacterial genome can have serious 
implications for the effectiveness of the antibiotic we use. Through whole genome sequencing, 
we can further understand the importance of mutations and the role that they play in antibiotic 
resistance. 
 
4.3 Plasmids (sequence types) 
Plasmid-mediated conjugation is one of the principal routes that aids the dissemination of 
antibiotic resistance genes (Wozniak & Waldor, 2010). To that end, databases to identify known 
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plasmid types have been developed to assist in the rapid detection of MDR Enterobacteriaceae 
from raw sequence data or contigs (Carattoli et al., 2014). The PlasmidFinder database is able to 
detect replicons in WGS and assign incompatibility (Inc) groups, while the pMLST Web tool is 
able to subtype plasmids, providing information about plasmid sequence types (STs) and any 
new variants or alleles. The information from these two databases provides an insight into 
possible lineage of plasmids on a global scale. 
 
Plasmids with Inc groups IncF, IncI, IncA/C, IncL, IncN and IncH have been reported as having 
the widest variety of resistance genes in Enterobacteriaceae (Rozwandowicz et al., 2018). The 
plasmid group IncA/C has been associated with resistance to aminoglycosides, β-lactams, 
chloramphenicol, tetracyclines and trimethoprim (Hoffmann et al., 2017), while other plasmid 
groups such as IncF, IncI and IncN have been identified as early carriers of β-lactam resistance 
genes (Tran-Dien et al., 2018). IncF, IncI, IncX and IncN plasmid groups have a narrow host 
range, and are usually found in Enterobacteriaceae (Musovic et al., 2006).  
 
4.4 Aims 
As mutations in the regulatory enzymes AcrR and MarR have been shown to increase multidrug 
resistance (Sadeghi, 2019; Wang et al., 2001), I wanted to explore whether the known point 
mutations could be identified in my isolates. I also wanted to observe whether mutations detected 
in the QRDR were predictive of ciprofloxacin resistance. Similarly, I wanted to investigate 





4.5 Strain selection 
20 isolates were selected for sequencing. Isolates were chosen for sequencing based on 
geographic criteria, resistance profiles or whether they were an ESBL or AmpC producer. The 
phenotype of the selected strains can be found in (Table 15). 
 
Table 15 Phenotype of the strains selected for sequencing. 
 
 
Whole genome sequencing (WGS) was done in collaboration with Dr Gayle Ferguson at Massey 
University in Auckland. Isolates were sequenced by Illumina MiSeq paired-end sequencing. 
Genomic DNA was prepared for both sequencing platforms using a Wizard Genomic DNA 
Purification Kit (Promega Corporation) according to the manufacturer’s instructions. DNA 
concentration and purity were quantified using a Qubit Fluorometer (Invitrogen).   Raw forward 
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and reverse sequences were uploaded to the Australian Galaxy server and the genome was 
assembled with Galaxy SPAdes genome assembler (Galaxy v3.12.0+galaxy1; (Afgan et al., 
2018), with parameters: no error correction, automatically chosen k-mer value and no coverage 
cut off. The genome was annotated in RAST version 2.0 (Aziz et al., 2008) using default settings 
(RASTtk annotation scheme, automatically fix errors, verbose level = 0). E. coli K12 MG1655 
(NCBI Accession number: U00096) was used as a reference strain for all analyses (Blattner et 
al., 1997). 
 
4.6 E. coli classification 
All E. coli isolates were serotyped using SerotypeFinder 2.0 v2.0.1 (Joensen et al., 2015). The 
threshold for sequence identity was 85%, and the minimum number of nucleotides a sequence 
must overlap was 65%. PathogenFinder v1.1 (Cosentino et al., 2013) was used to predict whether 
the E. coli isolates were human pathogens. Multi-Locus Sequence Typing (MLST) was 
performed using MLST 2.0 v2.0.4 (Larsen et al., 2012). Two MLST configurations were 
available for E. coli; Escherichiacoli#1, also known as Achtman configuration (Jolley et al., 
2018; Wirth et al., 2006), and Escherichiacoli#2, also known as Pasteur configuration (Jaureguy 
et al., 2008; Jolley et al., 2018). 
 
4.7 Antibiotic Resistance Genotyping 
ResFinder 4.1 (Bortolaia et al., 2020) was used to identify resistance genes. The PointFinder 
software (Zankari et al., 2017) was selected to be included in the analysis. This was to identify 
point mutations that could lead to resistance. For chromosomal point mutations, the threshold for 
sequence identity was 90%, and the minimum number of nucleotides a sequence must overlap 
was 60%. Identification of unknown mutations that are not found in the database was selected. 
Identification of acquired antimicrobial resistance genes was also selected to be a part of the 
analysis. All antimicrobial gene databases available were used. The threshold for sequence 
identity was 90%, and the minimum number of nucleotides a sequence must overlap was 60%. 
ClustalW Multiple Alignment (Thompson et al., 1994) with 1000 bootstrap replicates was used 




4.8 Plasmid Typing and Mobile Genetic Elements 
PlasmidFinder 2.1 v2.0.1 was used for plasmid detection (Carattoli et al., 2014). The threshold 
for sequence identity was 95%, and the minimum number of nucleotides a sequence must 
overlap was 60%. Plasmid Multi-Locus Sequence Typing (pMLST) was performed using 
pMLST 2.0 v0.1.0 (Carattoli et al., 2014). Two configurations were explored: IncF RST and 
IncI1 MSLT. Mobile Element Finder v1.0.3 (Johansson et al., 2020) was used to identify mobile 
genetic elements and their relation to antibiotic resistance and virulence factors. Acquired 
resistance genes and virulence gene databases were included in the analysis.  
 
4.9 Statistics 
I wanted to observe whether the mutations detected in the QRDR were predictive of 
ciprofloxacin resistance. I also wanted to investigate whether mutations in the AmpC promoter 
were predictive of the AmpC production phenotype. For both analyses, a generalized linear 




All strains were predicted to be human pathogens. This was due to the isolates harbouring genes 
that were associated with other known E. coli pathogens. Appendix D describes the 
PathogenFinder results, as well as the SerotypeFinder and MLST results. There was evidence of 
putative macrolide, lincosamide and streptogramin B resistance, as well as unknown macrolide, 
aminoglycoside, tetracycline, fluoroquinolone, phenicol and rifamycin resistance genes in all 
sequenced isolates. Strains OKANA4 and OM3 had predicted nalidixic acid and ciprofloxacin 
resistance genes. Disinfectant resistance was predicted for strains OM3, PC1C1 and S1A. All but 
two strains harboured mutations in the pmrA and pmrB genes. These are associated with colistin 
resistance (Table 16). Other point mutations of significance were also detected; however, the 
phenotypes were unknown. This information can be found in Appendix E1. Multidrug 
transporter mdfA was identified as a contributor to resistance for all strains except E. coli OM3. 
The mdfA genes from nine isolates were identified as being on a mobile genetic element 
associated with the IS families IS200/IS605 (n = 5) and IS630 (n = 8).  
 
Point mutations in the QRDR that are known to confer resistance to ciprofloxacin were detected 
in my isolates, however, there was no significant effect of these point mutations on the 
ciprofloxacin resistance phenotypes (Table 16). Other point mutations of significance were also 
detected, however, the phenotypes were unknown. This information can be found in Appendix 
E2. The multidrug efflux transport system emrE was identified in 11 strains. Point mutations in 
genes associated with colistin resistance were identified in 19 strains.  
 
No genes associated with ESBL-production were identified. The blaEC (allelic to ampC) 
detections in the isolates were not a perfect match to the reference strain E. coli K12 MG 1655. 
16 alleles of blaEC were detected. Point mutations in the ampC promoter sequence that have 
been associated with AmpC overexpression were identified, however, they had no significant 
effect on AmpC production in my isolates (Table 16). Other point mutations of significance were 





The strains OKANA4 and TRIBB22 both harboured the T213I and N214T alleles of acrR which 
have been associated with overexpression of the AcrAB-TolC efflux system. Strain OM3 
appeared to have a 2bp insertion at the end of the acrR sequence. Three isolates had deletions 
either at the beginning or the end of the marR gene. All isolates harbored the G103S point 
mutation allele, and 17 isolates harboured the Y137H point mutation allele. These mutations 
have been identified as leading to overexpression of the AcrAB-TolC efflux system, contributing 
to MDR. Other point mutations also were detected in marR. A sequence alignment of marR 
across the isolates can be seen in Figure 10. 
 
Plasmids were detected in 11 isolates. The most common plasmid incompatibility group detected 
by sequencing was IncF (n = 13). IncI (n = 2) and IncX (n = 2) incompatibility groups were also 
detected. Five isolates had more than one plasmid. Six isolates with plasmids were conjugative 
donors as shown in Chapter 3. One E. coli strain harboured a likely non-conjugative plasmid 
because it generated transconjugants at an undetectable frequency. Because the isolates were 
sequenced using the Illumina sequencing platform which generates short reads, I was unable to 




Table 16 Point mutations in the sequenced isolates that have been identified as contributing to a resistant phenotype. 
ampC promoter point mutations that are associated with overexpression. gyrA, gyrB, parC and parE mutations that 
are associated with ciprofloxacin resistance. pmrA and pmrB point mutations that are associated with colistin 
resistance. *E. coli K12 used as a reference strain. 
 
Figure 10 ClustalW alignment of marR across the sequenced isolates. Point mutations in marR that have been 
associated with overexpression of the AcrAB-TolC efflux system highlighted by the blue boxes. *Reference strain 
E. coli K12 
78 
 
Table 17 Results from PlasmidFinder and plasmid replicon database. *Novel allele detected, ST may indicate 
nearest ST; ? Imperfect hit, ST cannot be trusted; - No hits. 
E. coli 
strain 
Conjugative phenotype PlasmidFinder pMLST IncF RST 
pMLST IncI1 
MLST 
3OBA18 Not tested IncFIA(HI1) ST F-:A-:B- - 




ST F25:A-:B- - 
AB2A Ampicillin, chloramphenicol IncI(Gamma) - ST Unknown* 
AE1A - - - - 
K25 - - - - 





ST F19:A-:B-? - 
OM3 Not tested 
IncFIB(AP001918) 
IncFIC(FII) 




IncFIB(AP001918) ST F112:A-:B- - 
OVD31 Ampicillin, chloramphenicol IncFIB(AP001918) ST F112:A-:B- - 
PC1C1 - - ST F-:A-:B- - 
PC1C5 - - ST F35:A-:B- ST Unknown* 
S1A Not tested - ST F-:A-:B- - 
S2E - - St F-:A-:B- - 
SOU1 Not tested IncFIB(AP001918) ST F-:A-:B24 - 




ST F40:A-:B- ;  - 
UC15 - - No hits - 
WB3A6 Not tested 
IncI1_1_Alpha_AP005147  
IncFIB(pB171) 








Here I described 20 environmental E. coli isolates with various genotypes associated with 
antibiotic resistance. Overall, the phenotype was congruent with genotype. Based on the 
genotype information, AmpC overexpression, point mutations in target genes, and efflux systems 
are likely significant contributors to the MDR phenotypes. 
 
In E. coli, AmpC-mediated resistance is predominantly through overexpression of the 
chromosomal ampC, however, plasmid-mediated ampC can also confer resistance. AmpC is 
constitutively expressed in E. coli as it lacks the ampR regulator gene (Corvec et al., 2002). 
Overexpression of AmpC occurs from mutations in the AmpC promoter and attenuator regions 
which are thought to generate promoters that more closely resemble the E. coli consensus 
sequence (Corvec et al., 2002; Tracz et al., 2005). Previous studies have identified a pair of 
mutations in the ampC promoter that leads to increased expression. In my isolates, the pair was 
always identified together in a genome and was only identified in six strains even though 18 
strains displayed a AmpC-producing phenotype. Strains that harboured this pair were generally 
more resistant to cefotaxime or ceftazidime with the exception of strain OVD31. This suggests 
that these mutations are contributors to AmpC production, which is supported by other findings 
(Nelson & Elisha, 1999; Siu et al., 2003). There were 16 allelic variants of blaEC identified in 
my study, and none were identical to the reference E. coli K12 MG1655 or known blaEC 
sequences that were available on the NCBI database (blaEC-5, blaEC-8, blaEC-13, blaEC-14, blaEC-
15, blaEC-16, blaEC-18 and blaEC-19). Another common mutation I found in the promoter 
sequence was -28G>A (n = 5), however, this mutation had not been identified in the literature. 
The various AmpC and ESBL phenotypes could be attributed to these variations in blaEC. It 
could also be due to a combination of AmpC production and efflux systems. 
 
Fluoroquinolone resistance occurs through three main mechanisms; through mutations the gene 
sequences for DNA gyrase (gyrA and gyrB) and topoisomerase IV (parC and parE), through 
mutations that alter cell permeability, and through the acquisition of plasmids harbouring 
resistance genes (Hooper & Jacoby, 2015). The most commonly associated ciprofloxacin 
resistance mechanism is through specific mutations in the quinolone resistance-determining 
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region (QRDR) where gyrA, gyrB, parC and parE are present (Aldred et al., 2014). These 
mutations confer resistance by reducing ciprofloxacin’s binding affinity to the enzyme-DNA 
complex (Hooper & Jacoby, 2015; Jacoby, 2005). Various studies have discovered different 
amino acid substitutions at various locations within each gene that confer resistance to 
ciprofloxacin, however, the congruent finding is that a mutation in either DNA gyrase or 
topoisomerase IV alone is enough to increase ciprofloxacin resistance (Aldred et al., 2014; 
Heisig, 1996; Mbelle et al., 2019; Zhang et al., 2018). The presence of known point mutations in 
the QRDR that confer resistance to ciprofloxacin could not be significantly correlated with 
ciprofloxacin resistance in my isolates. The strongest predictor of a ciprofloxacin resistant 
phenotype was the gyrA D678E point mutation. There were many point mutations of significance 
that were detected in genes in the QRDR, however, most of them led to an unknown phenotype 
and had not been identified in the literature before. Sadeghi (2019) showed that E. coli with 
mutations in acrR and marR had higher ciprofloxacin MICs. 66% of the ciprofloxacin resistant 
isolates that had an MIC of 2μg mL-1 had large deletions in marR. Ciprofloxacin resistance in 
these isolates was likely due to a combination of mutations in efflux systems and the mutations 
in the target genes the QRDR. Colistin resistance was not something I tested for in my antibiotic 
susceptibility assay, however, PointFinder detected mutations in the pmrA and pmrB genes that 
have been associated with colistin resistance. There were other point mutations of significance 
that were detected in those genes that had unknown phenotype and had not been identified in the 
literature before.  
 
Studies have shown increased susceptibility to some antibiotics in strains that have the AcrAB-
TolC efflux system knocked out, showing that it is a contributor to resistance (Kurenbach et al., 
2017; Li et al., 2015; Sadeghi, 2019; Wang et al., 2001). Further, mutations in the repressors 
marR and acrR have been shown to lead to overexpression of the AcrAB-TolC efflux system, 
further contributing to antibiotic resistance. Point mutations that have been identified before by 
Sadeghi (2019) and Wang et al. (2001) were detected in the sequenced isolates. These mutations 
have been linked to increased fluoroquinolone and multidrug resistance. Overexpression of 
AcrAB-TolC has been shown to increase resistance to five of the antibiotics that I investigated 
(ampicillin, chloramphenicol, trimethoprim, kanamycin and ciprofloxacin) (Li et al., 2015). Two 
of the strains I isolated were conjugative donors and had mdfA on a mobile genetic element. 
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Unfortunately, plasmid sequences were unable to be extracted from the contigs, which hindered 
the ability to observe for plasmid-mediated resistant determinants. The multidrug efflux system 
EmrE was identified in 11 isolates. EmrE has been shown to confer resistance to 
aminoglycosides and is part of the SMR family (Nasie et al., 2012). Multidrug efflux transporters 
have been widely recognized as contributing to antibiotic resistance. E. coli have many 
multidrug efflux systems which contribute to resistance. AcrAB-TolC and MdfA were explored 
because AcrAB-TolC had been identified as being the key multidrug efflux system in E. coli and 
MdfA was predicted to be a contributor or resistance by ResFinder 4.1.  
 
4.10 Conclusions 
The key findings are that a combination of point mutations, efflux systems and AmpC 
−lactamases are the putative contributors to resistance phenotypes observed in the sequenced 
isolates. The contamination of antibiotic residues and other selective agents into surface waters 
can lead to adaptive responses in bacteria (Kurenbach et al., 2015; Lupo et al., 2012).  Through 
WGS we can identify the underlying genetic mechanisms that confer resistance, and further 
understand how the environment plays a role in antibiotic resistance. 
 
4.11 Final summary and future perspectives 
The story of the journey I describe begins with airplane water and flows all the way to WGS E. 
coli isolates. The key conclusions drawn from my thesis are that:  
1) E. coli were below the detection limit in both long haul and domestic airplane water, 
however, long haul planes had significantly higher microbial loads than domestic planes. 
As a species profile was not done for these isolates, a conclusion cannot be drawn on 
whether they were pathogenic or not. The overarching conclusion, however, is that 
passengers on long haul planes have opportunity to be exposed to water of poorer 
microbiological quality.  
2) Treating raw water from streams significantly reduces the concentration of E. coli that we 
may be exposed to, however, as total E. coli concentrations are not predictive of resistant 




3) MDR E. coli can be detected across the South Island of New Zealand. These isolates 
were resistant to antibiotics that are classed by the WHO as ‘critical’ or ‘highly 
important’ for human therapeutics. No significant difference in MDR counts were found 
between regions. Each region had different resistance profiles, which in some cases 
aligned with the anthropogenic activities that are dominant in those places.  
 
4) MDR E. coli were able to share their resistant determinants through horizontal gene 
transfer, and for some isolates, at a high frequency (1 x 10-1 cfu mL-1). ESBL- and 
AmpC-producing E. coli were also detected.  
 
5) Genetic analysis showed that point mutations, efflux systems and AmpC-production were 
like significant contributors to multidrug resistance. 
 
The study emphasized geographic range over replication depth. A limitation of this was that I 
was able to sample from many places, however, this meant that repeat samples were not always 
feasible to obtain from sites of interest. Further work could build on these results, focusing on 
areas where MDR E. coli were detected and investigating stronger links to land use patterns and 
MDR bacteria. Seasonal sampling of Okains Bay provided a glimpse into the different resistance 
profiles relative to different seasons. Further seasonal sampling would be beneficial to observe 
whether these resistance patterns are consistent, especially with the identification of 
ciprofloxacin resistant populations in autumn. Further analysis could observe whether the ESBL- 
and AmpC-producing genetic determinants can be shared through horizontal gene transfer. This 
would be an important analysis as ESBL- and AmpC-producing E. coli are an important threat to 
how antibiotics are used to treat infections and determining whether they can be disseminated in 
these surface waters would provide an insight into another possible vector of exposure.  
 
The isolates which were able to share resistant determinants at a high frequency could be 
sequenced. It would be interesting to observe the underling features that result in this 
observation. Mutations associated with colistin resistance were detected in some of the 
sequenced isolates. Further study could investigate the presence of colistin resistance in the 
environment. Colistin is an important last resort antibiotic for carbapenem-resistant 
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Enterobacteriaceae infections (Gharaibeh & Shatnawi, 2019), and determining the presence of 
colistin resistance genes in the New Zealand environment would be important endeavour. Based 
on my genotype results, AmpC overexpression, point mutations in target genes, and efflux 
systems are likely significant contributors to the MDR phenotypes. Further analysis could 
investigate the contribution of efflux systems and these point mutations to levels of resistance in 
environmental isolates.  
 
Antibiotic resistance is a global crisis, and mortalities associated with antibiotic resistant 
infections are predicted to increase to over 10 million by 2050 (Tagliabue & Rappuoli, 2018). 
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Appendix A: Statistical outputs for water quality and 
multidrug resistance analyses 
 
A1 Comparison of long haul vs short haul airplane water 
Mesophile counts between airplane water using glm. 
glm(formula = mesophile_per_100uL ~ haul, family = poisson(link = "log"),  data = airplane) 
 
Coefficients: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 5.09222     0.03919 129.926   < 2e-16 *** 
hauloverseas 0.32389     0.05145    6.295 3.07e-10 *** 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Emmeans post hoc analysis: 
Contrasts Estimate Std. Error z ratio p value 






















A2 Comparison of E. coli counts 
E. coli counts between drinking water sources using glmer. 
Generalized linear mixed model fit by maximum likelihood (Laplace Approximation)  
Family: poisson  ( log ) 




Groups Name Variance Std. Dev 
total2$obs_effect (Intercept) 0.02077   0.1441   
site               (Intercept) 9.65398   3.1071   
Number of obs: 36, groups:  total2$obs_effect, 36; site, 12 
 
Fixed effects: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 1.347       1.790    0.752 0.4518 
sourceStream 3.087       2.371    1.302 0.1929 
sourceTreated -6.091       2.628   -2.318 0.0205 * 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Correlation of Fixed Effects: 
 (Intr) srcStr 
sourceStrem -0.755  
sourceTretd -0.583 0.440 
 
Emmeans post hoc analysis: 
Contrasts Estimate Std. Error z ratio p value 
Other – Stream -3.09 2.37 -1.302 0.3940 
Other – Treated 6.09 2.63 2.318 0.0534 




















E. coli counts between and within regions using glmer. 
Generalized linear mixed model fit by maximum likelihood (Adaptive Gauss-Hermite Quadrature, nAGQ 
= 0)  
Family: poisson  ( log ) 




Groups Name Variance Std. Dev 
total2$obs_effect (Intercept) 0.02076   0.1441   
site               (Intercept) 3.53889   1.8812   
Number of obs: 36, groups:  mixed$obs_effect, 36; site, 12 
 
Fixed effects: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 5.482       1.883    2.911   0.00361 ** 
sourceStream -1.008       2.307      -0.437   0.66225 
sourceTreated -26.784   14794.141   -0.002   0.99856    
regionCant -26.787   14792.943   -0.002   0.99856    
regionMarl                   -3.118       2.354   -1.325   0.18532    
sourceStream:regionCant      28.352   14792.943    0.002   0.99847    
sourceTreated:regionCant     46.070   20921.228    0.002   0.99824    
sourceStream:regionMarl       1.416       3.299      0.429   0.66768 
sourceTreated:regionMarl      3.118   20922.074    0.000   0.99988    
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Correlation of Fixed Effects: 
 (Intr) srcStr srcTrt  rgnCnt  rgnMrl  srcS:C  srcT:C  srcS:M 
sourceStrem  -0.816        
sourceTretd   0.000   0.000                                               
regionCant    0.000   0.000   0.000        
regionMarl   -0.800   0.653   0.000   0.000                                
srcStrm:rgC   0.000   0.000   0.000  -1.000   0.000                        
srcTrtd:rgC   0.000   0.000  -0.707  -0.707   0.000   0.707                
srcStrm:rgM   0.571  -0.699   0.000   0.000  -0.714   0.000   0.000         
srcTrtd:rgM   0.000   0.000  -0.707   0.000   0.000   0.000   0.500   0.000 
 
Emmeans post hoc analysis: only p values less than 0.10 shown. 
Contrasts Estimate Std. Error z ratio p value 
Other Banks - Treated Cant 7.50e+00      2.57  2.914   0.0853 
Stream Banks - Treated Cant    6.49e+00      2.20  2.948   0.0778 





A3 Comparison of ampicillin resistant E. coli populations 
Ampicillin resistant E. coli in drinking water sources using glmer. 
Generalized linear mixed model fit by maximum likelihood (Laplace Approximation)  
Family: poisson  ( log ) 




Groups Name Variance Std. Dev 
amp_obs (Intercept) 0.2363    0.4861   
site               (Intercept) 6.7186  2.5920   
Number of obs: 36, groups:  amp_obs, 36; site, 12 
 
Fixed effects: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 0.4023      1.5305    0.263    0.7927   
sourceStream 1.9184      2.0115    0.954    0.3402   
sourceTreated -4.2604      2.2396   -1.902    0.0571 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Correlation of Fixed Effects: 
 (Intr) srcStr 
sourceStrem -0.757         
sourceTretd -0.562   0.429 
 
Emmeans post hoc analysis:  
Contrasts Estimate Std. Error z ratio p value 
Other - Stream       -1.92  2.01  -0.954   0.6062 
Other - Treated       4.26  2.24  1.902   0.1380 



















Ampicillin resistant E. coli between and within regions using glmer. 
Generalized linear mixed model fit by maximum likelihood (Adaptive Gauss-Hermite Quadrature, nAGQ 
= 0)  
Family: poisson  ( log ) 




Groups Name Variance Std. Dev 
total2$obs_effect (Intercept) 0.2300    0.4795   
site               (Intercept) 0.9755    0.9877   
Number of obs: 36, groups:  mixed$obs_effect, 36; site, 12 
 
Fixed effects: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 4.536e+00   1.028e+00    4.414  1.01e-05 *** 
sourceStream -1.039e+00   1.260e+00   -0.824   0.40979     
sourceTreated -2.584e+01     1.479e+04   -0.002   0.99861   
regionCant -2.584e+01   1.479e+04   -0.002   0.99861     
regionMarl                   -3.459e+00   1.307e+00   -2.646   0.00815 ** 
sourceStream:regionCant      2.481e+01   1.479e+04    0.002   0.99866     
sourceTreated:regionCant     4.590e+01   2.092e+04    0.002   0.99825     
sourceStream:regionMarl       -3.767e-02   1.904e+00   -0.020   0.98422     
sourceTreated:regionMarl      3.459e+00   2.092e+04    0.000   0.99987     
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Correlation of Fixed Effects: 
 (Intr) srcStr srcTrt  rgnCnt  rgnMrl  srcS:C  srcT:C  srcS:M 
sourceStrem  -0.815        
sourceTretd   0.000 0.000       
regionCant    0.000 0.000 0.000      
regionMarl   -0.786   0.641   0.000   0.000                                
srcStrm:rgC   0.000   0.000   0.000                   -1.000   0.000       
srcTrtd:rgC   0.000   0.000  -0.707  -0.707   0.000   0.707                
srcStrm:rgM   0.540        -0.662   0.000   0.000  -0.687   0.000   0.000  
srcTrtd:rgM   0.000   0.000  -0.707   0.000   0.000   0.000   0.500   0.000 
 
Emmeans post hoc analysis: only p values less than 0.10 shown. 
Contrasts Estimate Std. Error z ratio p value 
Other Banks - 
Treated Cant     
5.77e+00      1.47  3.936   0.0027 
Other Banks - 
Stream Marl      
4.54e+00      1.56  2.903   0.0879 
Stream Banks - 
Treated Cant    






A4 Comparison of ciprofloxacin resistant E. coli populations  
Ciprofloxacin resistant E. coli in drinking water sources analysis using glmer. 
Generalized linear mixed model fit by maximum likelihood (Adaptive Gauss-Hermite Quadrature, nAGQ 
= 0)  
Family: binomial  ( logit ) 




Groups Name Variance Std. Dev 
site               (Intercept) 5.885e-20  2.426e-10 
Number of obs: 36, groups:  site, 12 
 
Fixed effects: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) -21.57    10335.23   -0.002     0.998 
sourceStream 19.17    10335.23    0.002     0.999 
sourceTreated 19.96    10335.23    0.002     0.998 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Correlation of Fixed Effects: 
 (Intr) srcStr 
sourceStrem  -1.000                                                  


























Ciprofloxacin resistant E. coli between and within regions using glmer. 
Generalized linear mixed model fit by maximum likelihood (Adaptive Gauss-Hermite Quadrature, nAGQ 
= 0)  
Family: binomial  ( logit ) 
Formula: cip ~ source * region + (1 | site) 
Data: mixed  
 
Random effects 
Groups Name Variance Std. Dev 
site               (Intercept) 1.57e-15  3.963e-08 
Number of obs: 36, groups:  site, 12 
 
Fixed effects: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) -2.157e+01   1.688e+04   -0.001     0.999 
sourceStream -5.897e-06   2.067e+04    0.000     1.000 
sourceTreated 2.087e+01   1.688e+04    0.001     0.999 
regionCant -6.007e-06   2.387e+04    0.000     1.000 
regionMarl                   -4.902e-06   2.067e+04    0.000     1.000 
sourceStream:regionCant      5.897e-06   3.157e+04    0.000     1.000 
sourceTreated:regionCant     -2.087e+01   2.669e+04   -0.001     0.999 
sourceStream:regionMarl       2.087e+01   2.387e+04    0.001     0.999 
sourceTreated:regionMarl      -2.087e+01   2.669e+04   -0.001     0.999 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Correlation of Fixed Effects: 
 (Intr) srcStr srcTrt  rgnCnt  rgnMrl  srcS:C  srcT:C  srcS:M 
sourceStrem  -0.816                                                       
sourceTretd   -1.000   0.816                                                 
regionCant    -0.707   0.577   0.707                                       
regionMarl   -0.816   0.667   0.816   0.577                                
srcStrm:rgC   0.535  -0.655  -0.535  -0.756                    -0.436      
srcTrtd:rgC   0.632  -0.516  -0.632  -0.894  -0.516   0.676                
srcStrm:rgM   0.707      -0.866  -0.707  -0.500  -0.866   0.567   0.447    








A5 Comparison of chloramphenicol resistant E. coli 
populations 
Chloramphenicol resistant E. coli in drinking water sources analysis using 
glmer. 
Generalized linear mixed model fit by maximum likelihood (Adaptive Gauss-Hermite Quadrature, nAGQ 
= 0)  
Family: binomial  ( logit ) 
Formula: chl ~ source + (1 | site) 
Data: chlresistance  
 
Random effects: 
Groups Name Variance Std. Dev 
site               (Intercept) 10.31     3.212    
Number of obs: 26, groups:  site, 12 
 
Fixed effects: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) -2.257e+01   1.704e+04   -0.001     0.999 
sourceStream 2.152e+01   1.704e+04    0.001     0.999 
sourceTreated -8.177e-07   2.603e+04 0.000 1.000 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Correlation of Fixed Effects: 
 (Intr) srcStr 
sourceStrem  -1.000         























Chloramphenicol resistant E. coli between regions analysis using glmer. 
Generalized linear mixed model fit by maximum likelihood (Adaptive Gauss-Hermite Quadrature, nAGQ 
= 0)  
Family: binomial  ( logit ) 
Formula: chl ~ source * region + (1 | site) 
Data: mixed  
 
Random effects 
Groups Name Variance Std. Dev 
site               (Intercept) 1.655     1.286    
Number of obs: 36, groups:  site, 12 
 
Fixed effects: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) -2.257e+01   2.783e+04   -0.001     0.999 
sourceStream 2.337e+01   2.783e+04    0.001     0.999 
sourceTreated -2.668e-05   3.935e+04    0.000     1.000 
regionCant -2.668e-05   3.935e+04    0.000     1.000 
regionMarl                   -2.668e-05   3.408e+04    0.000     1.000 
sourceStream:regionCant      -2.337e+01   4.820e+04    0.000     1.000 
sourceTreated:regionCant     2.668e-05   5.206e+04    0.000     1.000 
sourceStream:regionMarl       -2.337e+01   4.400e+04   -0.001     1.000 
sourceTreated:regionMarl      2.668e-05   5.206e+04    0.000     1.000 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Correlation of Fixed Effects: 
 (Intr) srcStr srcTrt  rgnCnt  rgnMrl  srcS:C  srcT:C  srcS:M 
sourceStrem  -1.000                                                       
sourceTretd   -0.707   0.707                                                 
regionCant    -0.707                                      0.707   0.500      
regionMarl   -0.816   0.816   0.577   0.577                                
srcStrm:rgC   0.577  -0.577  -0.408                    -0.816  -0.471      
srcTrtd:rgC   0.535               -0.535  -0.756  -0.756  -0.436   0.617   
srcStrm:rgM   0.632        -0.632  -0.447  -0.447  -0.775   0.365   0.338  









A6 Okains Bay seasonal differences on E. coli counts 
The effect of season on E. coli counts using glmer. 
Generalized linear mixed model fit by maximum likelihood (Laplace Approximation)  
Family: poisson  ( log ) 




Groups Name Variance Std. Dev 
obs (Intercept) 1.327     1.152    
site               (Intercept) 1.126     1.061    
Number of obs: 67, groups:  obs, 67; site, 6 
 
Fixed effects: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 4.0875      0.5237    7.805  5.95e-15 *** 
seasonSpring   -0.2003      0.4215      -0.475   0.63470 
seasonAutumn   -1.1661      0.4123   -2.828   0.00468 ** 
seasonSummer    0.6821      0.4064    1.678   0.09330 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Correlation of Fixed Effects: 
 (Intr) srcStr srcTrt  
seasonSpring   -0.375                 
seasonAutumn   -0.403   0.478         
seasonSummer    -0.408   0.485   0.526 
 
Emmeans post hoc analysis: 
Contrasts Estimate Std. Error z ratio p value 
Winter - Spring     0.200  0.421  0.475   0.9646 
Winter - Autumn     1.166  0.412  2.828   0.0242 
Winter - Summer    -0.682  0.406  -1.678   0.3352 
Spring - Autumn     0.966  0.426  2.266   0.1061 
Spring - Summer    -0.882  0.420  -2.099   0.1535 








A7 Okains Bay seasonal differences on ampicillin resistant 
E. coli counts 
The effect of season on ampicillin resistant E. coli counts using glmer. 
Generalized linear mixed model fit by maximum likelihood (Adaptive Gauss-Hermite Quadrature, nAGQ 
= 0) 
Family: poisson  ( log ) 




Groups Name Variance Std. Dev 
obs (Intercept) 0.4802    0.6930   
site               (Intercept) 0.8012    0.8951   
Number of obs: 67, groups:  obs, 67; site, 6 
 
Fixed effects: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 3.6466      0.4087    8.923   < 2e-16 *** 
seasonSpring   -0.3679      0.2638   -1.394     0.163     
seasonAutumn   -25.0428   5488.8596   -0.005     0.996    
seasonSummer    -1.5973      0.2698   -5.920  3.22e-09 *** 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Correlation of Fixed Effects: 
 (Intr) srcStr srcTrt  
seasonSpring   -0.289                 
seasonAutumn   0.000   0.000         
seasonSummer    -0.309   0.435   0.000 
 
Emmeans post hoc analysis: 
Contrasts Estimate Std. Error z ratio p value 
Winter - Spring     0.368     0.264  1.394   0.5029 
Winter - Autumn     25.043  5488.860   0.005   1.0000 
Winter - Summer    1.597     0.270   5.920   <.0001 
Spring - Autumn     24.675  5488.860  0.004   1.0000 
Spring - Summer    1.229     0.284   4.335   0.0001 






A8 Okains Bay E. coli count differences across sites: Winter 
The variation of E. coli counts across the six sites in winter using glm. Bridge 
(B), Estuary (E), Camp Kitchen (K), Schoolhouse (S), Tributary (T), Upstream 
(U). 
glm(formula = ecoli ~ site, family = poisson(link = "log"), data = winter) 
 
Coefficients: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 4.05468     0.07603   53.331   < 2e-16 *** 
siteE         -0.55817     0.12602   -4.429  9.46e-06 *** 
siteK        -0.54812     0.12562   -4.363  1.28e-05 *** 
siteS         0.06706     0.10576    0.634    0.5260     
siteT         0.33977     0.13463      2.524    0.0116 * 
siteU         0.47073     0.09690    4.858  1.19e-06 *** 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Emmeans post hoc analysis: only p values less than 0.05 shown. 
Contrasts Estimate Std. Error z ratio p value 
B - E       0.5582  0.1260  4.429   0.0001 
B - K       0.5481  0.1256  4.363   0.0002 
B - U      -0.4707  0.0969  -4.858   <.0001 
E - S      -0.6252  0.1245  -5.021   <.0001 
E - T      -0.8979  0.1498  -5.993   <.0001 
E - U      -1.0289  0.1171  -8.787   <.0001 
K - S      -0.6152  0.1241  -4.956   <.0001 
K - T      -0.8879  0.1495  -5.940   <.0001 
K - U      -1.0188  0.1167  -8.733   <.0001 
S - U      -0.4037  0.0950  -4.251   0.0003 
 
The variation in ampicillin resistant E. coli counts across the six sites analysis. 
glm(formula = amp ~ site, family = poisson(link = "log"), data = winter) 
 
Coefficients: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 4.14841     0.07255   57.182   < 2e-16 *** 
siteE         -1.02752     0.14131   -7.271  3.56e-13 *** 
siteK        -1.16949     0.14904   -7.847  4.26e-15 *** 
siteS         -0.29826     0.11115   -2.683   0.00729 ** 
siteT         -0.19717     0.15651   -1.260   0.20774     
siteU         -0.22314     0.10882   -2.051   0.04031 *   
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Emmeans post hoc analysis: only p values less than 0.05 shown. 
Contrasts Estimate Std. Error z ratio p value 
B - E       1.0275  0.141   7.271   <.0001 
B - K       1.1695  0.149  7.847   <.0001 
E - S      -0.7293  0.148  -4.939   <.0001 
E - T      -0.8303  0.184  -4.507   0.0001 
E - U      -0.8044  0.146  -5.513   <.0001 
K - S -0.8712 0.155  -5.619   <.0001 
K - T -0.9723  0.190  -5.112   <.0001 
K - U      -0.9463  0.153  -6.170   <.0001 
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A9 Okains Bay E. coli count differences across sites: Spring 
The variation of E. coli counts across the six sites in spring using glm. Bridge 
(B), Estuary (E), Camp Kitchen (K), Schoolhouse (S), Tributary (T), Upstream 
(U). 
glm(formula = ecoli ~ site, family = poisson(link = "log"), data = spring) 
 
Coefficients: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 4.53618     0.05976   75.905   < 2e-16 *** 
siteE         -1.31730     0.13002  -10.132   < 2e-16 *** 
siteK        -3.43757     0.33865  -10.151   < 2e-16 *** 
siteS         0.57179     0.07475    7.649  2.02e-14 *** 
siteU         -0.43629     0.09537   -4.575  4.77e-06 *** 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Emmeans post hoc analysis: only p values less than 0.05 shown. 
Contrasts Estimate Std. Error z ratio p value 
B - E        1.317  0.1300  10.132  <.0001 
B – K 3.438 0.3386 -7.649 <.0001 
B – U 0.436 0.0954 4.575 <.0001 
E – K 2.120 0.3528 6.010 <.0001 
E – S -1.889 0.1239 -15.248 <.0001 
E – U -0.881 0.1373 -6.415 <.0001 
K – S -4.009 0.3363 -11.920 <.0001 
K – U -3.001 0.3415 -8.788 <.0001 
S – U 1.008 0.0868 11.609 <.0001 
 
Variation of ampicillin resistant E. coli counts across the six sites in spring using 
glm. 
glm(formula = amp ~ site, family = poisson(link = "log"), data = spring) 
 
Coefficients: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 4.20966 0.07036 59.830 < 2e-16 *** 
siteE         -1.24782 0.14897 -8.376 < 2e-16 *** 
siteK        -3.92197 0.50493 -7.767 8.01e-15 *** 
siteS         -0.12648 0.10280 -1.230 0.219 
siteU         -0.67354 0.12108 -5.563 2.65e-08 *** 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Emmeans post hoc analysis: only p values less than 0.05 shown. 
Contrasts Estimate Std. Error z ratio p value 
B – E 1.248 0.149 8.376 <.0001 
B – K 3.922 0.505 7.767 <.0001 
B – U 0.674 0.121 5.563 <.0001 
E – K 2.674 0.517 5.173 <.0001 
E – S -1.121 0.151 -7.417 <.0001 
E – U -0.574 0.164 -3.498 0.0043 
K – S -3.795 0.506 -7.507 <.0001 
K – U -3.248 0.510 -6.374 <.0001 
S – U 0.547 0.124 4.419 0.0001 
Variation of chloramphenicol resistant E. coli counts across the six sites in 
spring using glm. 
glm(formula = chl ~ site, family = poisson(link = "log"), data = spring) 
 
Coefficients: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 0.2877 0.5000 0.575 0.565 
siteE         -20.5903 8973.0992 -0.002 0.998 
siteK        -20.5903 8973.0992 -0.002 0.998 
siteS         2.4423 0.5213 4.685 2.8e-06 *** 
siteU         0.5596 0.6268 0.893 0.372 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Emmeans post hoc analysis: only p values less than 0.05 shown. 
Contrasts Estimate Std. Error z ratio p value 
B – S -2.44 5.21e-01 -4.685 <.0001 































A10 Okains Bay E. coli count differences across sites: 
Autumn 
Variation of E. coli counts across the six sites in autumn using glm. (B), Estuary 
(E), Camp Kitchen (K), Schoolhouse (S), Tributary (T), Upstream (U). 
glm(formula = ecoli ~ site, family = poisson(link = "log"), data = aut) 
 
Coefficients: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 4.65713 0.05625 82.787 < 2e-16 *** 
siteE         -3.96398 0.41211 -9.619 < 2e-16 *** 
siteK        -1.36129 0.12454 -10.931 < 2e-16 *** 
siteT         -0.65588 0.09624 -6.815 9.43e-12 *** 
siteU         -0.14261 0.08255 -1.728 0.0841 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Emmeans post hoc analysis: only p values less than 0.05 shown. 
Contrasts Estimate Std. Error z ratio p value 
B – E 3.964 0.4121 9.619 <.0001 
B – K 1.361 0.1245 10.931 <.0001 
B – T 0.656 0.0962 6.815 <.0001 
E – K -2.603 0.4231 -6.151 <.0001 
E – T -3.308 0.4156 -7.959 <.0001 
E - U -3.821 0.4127 -9.260 <.0001 
K – T -0.705 0.1358 -5.194 <.0001 
K – U -1.219 0.1265 -9.636 <.0001 
T – U -0.513 0.0987 -5.199 <.0001 
 
Variation of ciprofloxacin resistant E. coli counts across the six sites in autumn 
using glm. 
glm(formula = cip ~ site, family = poisson(link = "log"), data = aut) 
 
Coefficients: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 3.71357 0.09017 41.186 < 2e-16 *** 
siteE         -4.81218 1.00403 -4.793 1.64e-06 *** 
siteK        -3.02042 0.41809 -7.224 5.03e-13 *** 
siteT         -0.62253 0.15258 -4.080 4.50e-05 *** 
siteU         0.11507 0.12400 0.928 0.353 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Emmeans post hoc analysis: only p values less than 0.05 shown. 
Contrasts Estimate Std. Error z ratio p value 
B – E 4.812 1.004 4.793 <.0001 
B – K 3.020 0.418 7.224 <.0001 
B – T 0.623 0.153 4.080 0.0004 
E – T -4.190 1.008 -4.158 0.0003 
E – U -4.927 1.004 -4.910 <.0001 
K – T -2.398 0.426 -5.624 <.0001 
K – U -3.135 0.417 -7.519 <.0001 
T – U -0.738 0.150 -4.929 <.0001 
 
A11 Okains Bay E. coli count differences across sites: 
Summer 
Variation of E. coli counts across the six sites in summer using glm. (B), Estuary 
(E), Camp Kitchen (K), Schoolhouse (S), Tributary (T), Upstream (U). 
glm(formula = ecoli ~ site, family = poisson(link = "log"), data = summer) 
 
Coefficients: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 5.99479 0.02882 208.012 < 2e-16 *** 
siteE         -7.09340 1.00039 -7.091 1.33e-12 *** 
siteK        -1.45862 0.06635 -21.984 < 2e-16 *** 
siteS -0.19772 0.04293 -4.606 4.10e-06 *** 
siteT         0.91296 0.03412 26.761 < 2e-16 *** 
siteU         -1.06513 0.05692 -18.712 < 2e-16 *** 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Emmeans post hoc analysis: only p values less than 0.05 shown. 
Contrasts Estimate Std. Error z ratio p value 
B – E 7.093 1.0004 7.091 <.0001 
B – K 1.459 0.0663 21.984 <.0001 
B – S 0.198 0.0429 4.606 0.0001 
B – T -0.913 0.0341 -26.761 <.0001 
B – U 1.065 0.0569 18.712 <.0001 
E – K -5.635 1.0018 -5.625 <.0001 
E – S -6.896 1.0005 -6.892 <.0001 
E – T -8.006 1.0001 -8.005 <.0001 
E – U -6.028 1.0012 -6.021 <.0001 
K – S -1.261 0.0677 -18.624 <.0001 
K – T -2.372 0.0625 -37.952 <.0001 
K – U -0.393 0.0773 -5.088 <.0001 
S – T -1.111 0.0367 -30.280 <.0001 
S – U 0.867 0.0585 14.828 <.0001 


















The variation of ampicillin resistant E. coli counts across the six sites in summer 
using glm. 
glm(formula = amp ~ site, family = poisson(link = "log"), data = summer) 
 
Coefficients: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 3.1918 0.1170 27.271 < 2e-16 *** 
siteE         -4.2905 1.0068 -4.261 2.03e-05 *** 
siteK        -2.4987 0.4247 -5.884 4.02e-09 *** 
siteS 0.7068 0.1430 4.942 7.75e-07 *** 
siteT         -0.1633 0.1727 -0.946 0.344 
siteU         -2.9042 0.5135 -5.655 1.55e-08 *** 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Emmeans post hoc analysis: only p values less than 0.05 shown. 
Contrasts Estimate Std. Error z ratio p value 
B – E 4.290 1.007 4.261 0.0003 
B – K 2.499 0.425 5.884 <.0001 
B – S -0.707 0.143 5.884 <.0001 
B – U 2.904 0.514 5.655 <.0001 
E – S -4.997 1.003 -4.981 <.0001 
E – T -4.127 1.008 -4.094 0.0006 
K – S -3.205 0.416 -7.697 <.0001 
K – T -2.335 0.428 -5.462 <.0001 
S – T 0.870 0.151 5.751 <.0001 
S – U 3.611 0.507 7.126 <.0001 























A12 Comparison of multidrug resistant E. coli 
The comparison of multidrug resistant E. coli in drinking water sources using 
glmer. 
Generalized linear mixed model fit by maximum likelihood (Laplace Approximation) [glmerMod] 
Family: poisson  ( log ) 




Groups Name Variance Std. Dev 
mdr$obs_effect (Intercept) 0.268 0.5177 
site               (Intercept) 5.491 2.3432 
Number of obs: 36, groups:  mdr$obs_effect, 36; site, 12 
 
Fixed effects: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 0.8971 1.3593 0.660 0.5092 
sourceStream 1.3552 1.8035 0.751 0.4524 
sourceTreated -3.9775 1.9836 -2.005 0.0449 * 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Correlation of Fixed Effects: 
 (Intr) srcStr 
sourceStrem  -0.753  
sourceTretd   -0.623 0.470 
   
Emmeans post hoc analysis:  
Contrasts Estimate Std. Error z ratio p value 
River – Stream -1.36 1.80 -0.751 0.7327 
River – Treated 3.98 1.98 2.005 0.1109 



















The comparison of multidrug resistant E. coli between and within regions using 
glmer. 
Generalized linear mixed model fit by maximum likelihood (Adaptive Gauss-Hermite Quadrature, nAGQ 
= 0) [glmerMod] 
Family: poisson  ( log ) 




Groups Name Variance Std. Dev 
mdr$obs_effect (Intercept) 0.2638 0.5136 
site               (Intercept) 1.6710 1.2927 
Number of obs: 36, groups:  mdr$obs_effect, 36; site, 12 
 
Fixed effects: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 4.251 1.329 3.200 0.00137 ** 
sourceStream -2.483 1.635 -1.519 0.12881 
sourceTreated -5.357 2.127 -2.518 0.01180 * 
regionCant -23.554 5442.434 -0.004 0.99655 
regionMarl                   -2.521 1.671 -1.509 0.13140 
sourceStream:regionCant      26.256 5442.434 0.005 0.99615 
sourceTreated:regionCant     22.750 5442.434 0.004 0.99666 
sourceStream:regionMarl       1.955 2.358 0.829 0.40700 
sourceTreated:regionMarl      -15.676 5442.460 -0.003 0.99770 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Correlation of Fixed Effects: 
 (Intr) srcStr srcTrt  rgnCnt  rgnMrl  srcS:C  srcT:C  srcS:M 
sourceStrem  -0.813        
sourceTretd   -0.625 0.507       
regionCant    0.000 0.000 0.000      
regionMarl   -0.795 0.646 0.496 0.000     
srcStrm:rgC   0.000 0.000 0.000 -1.000 0.000    
srcTrtd:rgC   0.000 0.000 0.000 -1.000 0.000 1.000   
srcStrm:rgM   0.563 -0.693 -0.352 0.000 -0.709 0.000 0.000  
srcTrtd:rgM   0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
         
Emmeans post hoc analysis: only p values less than 0.05 shown. 
Contrasts Estimate Std. Error z ratio p value 
River Banks - Treated Cant    6.16e+00     1.94 3.181 0.0393 







A13 Okains Bay seasonal differences on multidrug resistant 
E. coli 
The comparison of multidrug resistant E. coli across seasons in Okains Bay. (B), 
Estuary (E), Camp Kitchen (K), Schoolhouse (S), Tributary (T), Upstream (U). 
Generalized linear mixed model fit by maximum likelihood (Laplace Approximation) [glmerMod] 
Family: poisson  ( log ) 




Groups Name Variance Std. Dev 
strain           (Intercept) 0.6625 0.8139 
Number of obs: 24, groups:  strain, 24 
 
Fixed effects: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) -0.1704 0.5968 -0.286 0.775 
seasonSpring 0.5246 0.7210 0.728 0.467 
seasonSummer 0.2849 0.7329 0.389 0.698 
seasonWinter 0.7546 0.7066 1.068 0.286 
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Correlation of Fixed Effects: 
 (Intr) ssnSpr ssnSmm 
seasonSpring -0.746   
seasonSummer -0.714 0.563  
seasonWinter -0.759 0.592 0.574 
   
Emmeans post hoc analysis: 
Contrasts Estimate Std. Error z ratio p value 
Autumn - Spring    -0.525 0.721 -0.728 0.8860 
Autumn - Summer    -0.285 0.733 -0.389 0.9801 
Autumn - Winter    -0.755 0.707 -1.068 0.7091 
Spring - Summer     0.240 0.680 0.353 0.9849 
Spring - Winter    -0.230 0.645 -0.357 0.9845 















The comparison of multidrug resistant E. coli across sites in Okains Bay. 
Generalized linear mixed model fit by maximum likelihood (Adaptive Gauss-Hermite Quadrature, nAGQ 
= 0) [glmerMod] 
Family: poisson  ( log ) 




Groups Name Variance Std. Dev 
strain           (Intercept) 5.534e-18 2.352e-09 
Number of obs: 27, groups:  strain, 27 
 
Fixed effects: 
 Estimate Std. Error z value Pr(>|z|)     
(Intercept) 1.253e+00 2.673e-01    4.687 2.77e-06 *** 
siteE -8.473e-01   4.879e-01   -1.737    0.0825 
siteK -1.540e+00   6.360e-01   -2.422    0.0154 *   
siteResidential 1.362e+00   3.095e-01    4.401  1.08e-05 *** 
siteS -1.253e+00   5.669e-01   -2.210    0.0271 *   
siteT -2.639e+00   1.035e+00   -2.550    0.0108 *   
siteU -2.763e-12   3.780e-01    0.000    1.0000     
Signif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1 
 
Correlation of Fixed Effects: 
 (Intr) siteE siteK stRsdn siteS siteT 
siteE -0.548      
siteK -0.420 0.230     
siteResdntl -0.863 0.473 0.363    
siteS -0.471 0.258 0.198 0.407   
siteT -0.258 0.141 0.108 0.223 0.122  
siteU -0.707 0.387 0.297 0.611 0.333 0.183 
   
Emmeans post hoc analysis: only p values less than 0.05 shown. 
Contrasts Estimate Std. Error z ratio p value 
B – Residential -1.362 0.310 -4.401 0.0002 
E – Residential -2.209 0.437 -5.055 <.0001 
K – Residential -2.903 0.598 -4.855 <.0001 
Residential – S 2.615 0.524 4.992 <.0001 
Residential – T 4.001 1.012 3.953 0.0015 




Appendix B: MDR E. coli isolates from the antibiotic susceptibility assay 
Phenotypic confirmation of antibiotic susceptibility profiles of MDR isolates including the ESBL screening information. MDR 
phenotype includes resistance to Ctx, Cla, Ctx/Cla and Caz/Cla. 0 = Susceptible; 1 = Intermediate Resistance; 2 = Resistant; - = 
Not tested. Please see Abbreviations list at the beginning of this thesis for abbreviation definitions.  







OB2A4 Other BP 2 1 0 0 0 0 2 2 - - - - 
OB18 Other BP 2 0 0 0 0 0 2 0 2 0 2 0 
OB21 Other BP 2 0 0 0 0 0 2 2 - - - - 
2OB1G9 Other BP 2 0 2 0 2 0 2 0 - - - - 
2OB1G10 Other BP 2 0 0 0 2 0 1 2 - - - - 
3OB1A3 Other BP 2 0 0 0 0 2 2 0 - - - - 
3OB1A10 Other BP 2 0 0 0 0 2 2 2 - - - - 
3OB1A15 Other BP 2 0 0 0 0 2 2 0 - - - - 
3OA18 Other BP 2 1 0 0 0 0 2 2 0 0 0 0 
3OB1A11 Other BP 2 0 0 0 0 2 2 2 2 0 2 0 
3OB1A1001 Other BP 2 0 0 0 0 2 2 0 2 0 2 0 
3OB1A1003 Other BP 2 0 0 0 2 0 2 0 - - - - 
3OB2A12 Other BP 2 0 0 0 2 0 2 0 - - - - 
3OB2A5 Other BP 2 0 0 0 2 2 2 0 - - - - 
3OB2A3 Other BP 2 0 0 0 0 2 1 2 - - - - 
3OG10 Other BP 2 1 0 0 0 0 2 2 2 0 0 0 
SOU1 Other BP 0 0 2 0 1 0 2 0 2 0 2 0 
AUS1C Stream BP 2 0 0 0 0 0 1 0 2 0 2 0 
AUS3A Stream BP 2 0 0 0 0 0 2 0 2 0 2 0 
AB1A Stream BP 1 0 0 1 2 0 2 0 2 0 2 0 
AB2A Stream BP 2 1 0 1 2 0 2 0 2 0 2 0 
AB2C Stream BP 1 1 0 1 0 0 2 0 2 0 2 0 
AS1A Stream BP 1 0 0 0 1 0 2 0 2 0 2 0 
AS3A Stream BP 1 1 0 0 0 0 2 0 2 0 2 0 
AE1A Stream BP 1 0 0 0 2 0 2 0 2 0 2 0 
AE2G Stream BP 1 0 0 0 1 0 2 0 2 0 2 0 
ATG Stream BP 1 0 0 0 1 0 2 0 2 0 2 0 
AE1J Stream BP 2 1 0 0 0 0 2 0 2 0 2 0 
U2CHL Stream BP 2 0 2 1 2 0 2 0 0 0 0 0 
S2E Stream BP 2 0 0 0 2 0 2 0 2 0 2 0 
S1A Stream BP 2 0 0 0 1 0 1 0 2 2 2 0 
U2CHL Stream BP 0 0 0 2 0 0 2 0 2 0 2 0 
U32 Stream BP 0 0 0 0 0 0 0 2 2 0 2 0 
U1C5 Stream BP 2 1 0 0 0 0 0 2 2 2 0 2 
U14 Stream BP 0 0 0 1 0 0 0 2 2 0 2 0 
TRIB3C4 Stream BP 0 0 0 1 0 0 1 2 2 2 2 2 
TRIB22 Stream BP 1 1 0 1 0 0 1 2 2 0 2 0 
TRIB12 Stream BP 1 1 0 1 0 0 1 2 2 0 2 0 
PC3C5 Stream BP 0 0 0 1 0 0 1 2 2 0 2 0 
PC2C1 Stream BP 2 2 0 1 0 0 0 2 2 0 2 0 
PC2AMP Stream BP 2 0 0 2 0 0 1 2 2 0 2 0 
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PC1C5 Stream BP 1 2 0 1 0 0 1 2 2 0 2 0 
PC1C1 Stream BP 2 2 0 2 0 0 0 2 0 2 0 2 
OVU35 Other BP 1 0 2 1 0 2 1 2 - - - - 
OVU2C5 Other BP 0 0 0 1 0 0 0 2 2 0 2 0 
OVU2C1 Other BP 0 0 0 1 0 0 0 2 2 0 2 0 
OVD31 Other BP 1 1 0 1 0 0 1 2 2 0 2 0 
OVD13 Other BP 1 0 0 0 0 0 1 2 0 2 0 2 
OVD12 Other BP 1 1 0 1 0 0 1 2 2 2 0 0 
OVD11 Other BP 0 1 0 1 0 0 1 2 2 0 2 0 
OKANACHL Other BP 2 2 0 2 0 2 1 2 0 0 0 0 
OKANAAMP Other BP 2 2 0 2 0 2 1 2 0 0 0 0 
OKANA4 Other BP 1 0 0 0 0 0 0 2 0 2 0 2 
LRC1CIP Treated BP 0 0 0 0 1 2 1 2 2 2 2 2 
K25 Stream BP 1 1 0 1 0 0 0 2 2 0 2 0 
E21 Stream BP 0 1 0 0 0 0 1 2 2 0 2 0 
E1CIP Stream BP 1 1 0 0 0 0 1 2 2 0 2 0 
B3C3 Stream BP 0 0 2 0 0 0 1 2 0 2 0 2 
B1C1 Stream BP 0 1 0 0 0 0 1 2 0 2 0 2 
AU12 Stream BP 2 0 0 2 0 0 2 0 - - - - 
OM3A Treated C 2 0 0 2 0 0 2 0 0 2 0 2 
SF11 Stream C 2 0 0 2 0 0 2 2 - - - - 
SF12 Stream C 2 0 0 2 0 0 2 2 0 0 0 0 
SF13 Stream C 1 0 0 2 0 0 2 2 0 0 0 0 
SF15 Stream C 1 0 0 2 0 0 2 2 0 0 0 0 
SF17 Stream C 2 0 0 2 0 0 2 2 - - - - 
SF19 Stream C 2 0 0 2 0 0 2 2 - - - - 
SF10 Stream C 2 0 0 2 0 0 0 2 - - - - 
WHI22A Stream MS 2 0 2 0 0 0 0 2 0 0 0 0 
WHI22C Stream MS 2 0 2 0 0 0 0 2 0 2 0 0 
WHI23A Stream MS 2 0 2 0 0 0 0 2 0 0 0 0 
WHI24A Stream MS 2 0 2 2 0 0 0 2 0 0 0 0 
WHA11 Other MS 2 2 0 2 0 0 2 0 - - - - 
WHA12 Other MS 2 2 0 2 0 0 2 0 - - - - 
WHA13 Other MS 2 2 0 2 2 0 2 0 - - - - 
WHA14 Other MS 2 0 0 2 1 0 2 0 - - - - 
WHA15 Other MS 2 1 0 2 0 0 2 0 - - - - 
WHA16 Other MS 2 2 0 2 0 0 2 0 - - - - 
WHA17 Other MS 2 1 0 2 0 0 2 0 - - - - 
WHA18 Other MS 2 0 0 2 0 0 2 0 - - - - 
WHA19 Other MS 2 0 0 2 0 0 2 0 - - - - 
WHA10 Other MS 2 0 0 2 0 0 2 0 - - - - 
WHA24 Other MS 0 2 0 0 0 0 2 2 0 0 0 0 
2WHA3A6 Other MS 2 0 0 1 0 0 2 2 2 2 2 0 
WB3A6 Other MS 2 0 0 1 0 0 2 2 2 2 2 0 
3WHA32 Other MS 1 1 0 1 2 0 2 0 2 0 2 0 




Appendix C: ESBL- and AmpC-producing isolates 
Isolates with phenotypic confirmation of ESBL- or AmpC-production. *ESBL-producer; S = Susceptible; R = Resistant. Please 
see Abbreviations list at the beginning of this thesis for abbreviation definitions. 
E. coli strain AmpR CipR CTX CAZ CTX / CLA CAZ / CLA Isolated from Location 
2WHA26 R S R S R R Other MS 
2WHA37 R S R S R R Other MS 
3OB1A14 R S R S R R Other BP 
OB2 R R R S R R Other BP 
OB2A11 R R R S R R Other BP 
OB2A9 R R R S R R Other BP 
OKANACHL R R R S R R Other BP 
OVD11* S R R S S S Other BP 
OVD12* S R R S S S Other BP 
OVD13* S R S R S S Other BP 
OVD1C1* S R R R S S Other BP 
OVD21 S R R S R R Other BP 
OVD31 S R S R R R Other BP 
OVU24 S R R R R R Other BP 
OVU2C5 S R R S R R Other BP 
WHA24 S R R R R R Other MS 
1B4A R R R S R R Stream BP 
3B4A R R R S R R Stream BP 
AB2A R S R R R R Stream BP 
AS2A R S R S R R Stream BP 
AUS1D R S R S R R Stream BP 
AUS2B S S R S R R Stream BP 
B1C1* S R R R R R Stream BP 
B2CHL S R S R R R Stream BP 
E21 S R R S R R Stream BP 
E2B* R R R S S S Stream BP 
E31 S R R S R R Stream BP 
K13 S R R R R R Stream BP 
K25 S R R S R R Stream BP 
K3C3 S R R S R R Stream BP 
PC1C5 S R R S R R Stream BP 
PC21 S R R S R R Stream BP 
PC2AMP R R S R R R Stream BP 
PC2C1 R R R R R R Stream BP 
SF1* R R S R S S Stream C 
WHI23A R R R S R R Stream MS 
WHI24B R S R S R R Stream MS 




Appendix D: Classification of the sequences E. coli isolates 
Results from SerotypeFinder 2.0 v2.0.1, Pathogen Finder v1.1 and MLST 2.0 v2.0.4. ST = sequence type; *Novel ST. 
E. coli strain Serotype Predicted Human Pathogen MLST E. coli #1 MLST E. coli #2 
3OBA18 O27:H46 0.941 ST Unknown Nearest ST273* 
3OG10 O27:H46 0.941 ST Unknown ST Unknown* 
AB1A O4:H5 0.923 ST1 ST Unknown 
AB2A O39:H28 0.941 ST6096 ST726 
AE1A  0.937 ST8979 ST Unknown* 
K25 O8:H10 0.93 ST681 ST304 
LRC1C O98:H41 0.937 ST1087 ST Unknown* 
OKANA4 O17/O77:H34 0.943 ST Unknown* ST816 
OM3 O103:H56 0.891 ST5260 Nearest ST989* 
OVD12 O156:H7 0.945 ST2539 ST323 
OVD31 O156:H7 0.944 ST2539 ST323 
PC1C1 H10^ 0.941 ST1865* Nearest ST803 
PC1C5 O166:H15 0.935 ST349 ST678* 
S1A O170:H5 0.937 ST3307 Nearest ST324 
S2E O27:H46 0.941 ST Unknown ST Unknown* 
SOU1 O87:H6 0.939 ST3303 ST725 
TRIB22 H9^ 0.939 ST Unknown* ST Unknown* 
UC15 O8:H10 0.933 ST681 ST304 
WB3A6 O88:H8 0.937 ST446 ST397 






Appendix E: Point mutations with unknown phenotypes  
E1: Point mutations in pmrA, pmrB and ampC that were identified in PointFinder. These mutations were associated with resistance; however, the phenotype was unknown. 





E2: Point mutations gyrA and gyrB that were identified in PointFinder. These mutations were associated with resistance; however, the phenotype was unknown. 







E3: Point mutations in parC and parE that were identified in PointFinder. These mutations were associated with resistance, however, the phenotype was unknown. ^indicates point 
mutations that have been identified in the literature before.
 
